{"SLR NAME":"Clinical, laboratory and imaging characteristics of children with COVID-19: a systematic review and meta-analysis","References":[{"title1":"A Novel Coronavirus from Patients with Pneumonia in China, 2019","References":[{"title2":"From &quot;A&quot;IV to &quot;Z&quot;IKV: attacks from emerging and re-emerging pathogens.","References":[]},{"title2":"Coronavirus pathogenesis.","References":[{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"The coronavirus disease 2019 (COVID-19) pandemic"},{"title3":"Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?"},{"title3":"COVID-19 acute respiratory distress syndrome (ARDS): clinical features and differences from typical pre-COVID-19 ARDS"},{"title3":"Covid19, beyond just the lungs: a review of multisystemic involvement by Covid19"},{"title3":"In-vivo evidence of systemic endothelial vascular dysfunction in COVID-19"},{"title3":"Use of cardiopulmonary stress testing for patients with unexplained dyspnea post-coronavirus disease"},{"title3":"Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"},{"title3":"Pathophysiological association of endothelial dysfunction with fatal outcome in COVID-19"},{"title3":"Pulmonary endothelial dysfunction and thrombotic complications in patients with COVID-19"},{"title3":"COVID-19: the vasculature unleashed"},{"title3":"Patterns of inflammatory cell infiltration and expression of STAT6 in the lungs of patients with COVID-19: an autopsy study"},{"title3":"Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation"},{"title3":"The spatial landscape of lung pathology during COVID-19 progression"},{"title3":"A molecular single-cell lung atlas of lethal COVID-19"},{"title3":"Collagen-producing lung cell atlas identifies multiple subsets with distinct localization and relevance to fibrosis"},{"title3":"The pulmonary vasculature in lethal COVID-19 and idiopathic pulmonary fibrosis at single cell resolution"},{"title3":"Endothelial deficiency of insulin-like growth factor-1 receptor reduces endothelial barrier function and promotes atherosclerosis in Apoe-deficient mice"},{"title3":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19"},{"title3":"Spatial mapping of SARS-CoV-2 and H1N1 lung injury identifies differential transcriptional signatures"},{"title3":"Profiling of lung SARS-CoV-2 and influenza virus infection dissects virus-specific host responses and gene signatures"},{"title3":"Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infection"},{"title3":"Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study"},{"title3":"Acute myocarditis caused by COVID-19 disease and following COVID-19 vaccination"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Physiology of cardiomyocyte injury in COVID-19"},{"title3":"SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes"},{"title3":"The SARS-CoV-2 main protease M(pro) causes microvascular brain pathology by cleaving NEMO in brain endothelial cells"},{"title3":"The cross-talk of lung and heart complications in COVID-19: endothelial cells dysfunction, thrombosis, and treatment"},{"title3":"COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets"},{"title3":"Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry"},{"title3":"SARS-CoV-2 productively infects human brain microvascular endothelial cells"},{"title3":"The good treatment, the bad virus, and the ugly inflammation: pathophysiology of kidney involvement during COVID-19"},{"title3":"Pathophysiology of COVID-19-associated acute kidney injury"},{"title3":"Endothelial dysfunction for acute kidney injury in coronavirus disease 2019: how concerned should we be?"},{"title3":"Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches"},{"title3":"Vascular endothelial damage in the pathogenesis of organ injury in severe COVID-19"},{"title3":"Circulating endothelial cells as a marker of endothelial injury in severe COVID -19"},{"title3":"COVID-19 and the endothelium"},{"title3":"Emerging role of neuropilin-1 and angiotensin-converting enzyme-2 in renal carcinoma-associated COVID-19 pathogenesis"},{"title3":"Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development"},{"title3":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor"},{"title3":"Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19"},{"title3":"COVID-19 vasculopathy: mounting evidence for an indirect mechanism of endothelial injury"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes"},{"title3":"Lack of evidence of angiotensin-converting enzyme 2 expression and replicative infection by SARS-CoV-2 in human endothelial cells"},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China"},{"title3":"SARS-CoV-2 cell entry receptor ACE2 mediated endothelial dysfunction leads to vascular thrombosis in COVID-19 patients"},{"title3":"Heart-lung interactions in COVID-19: prognostic impact and usefulness of bedside echocardiography for monitoring of the right ventricle involvement"},{"title3":"Endothelial cell dysfunction, coagulation, and angiogenesis in coronavirus disease 2019 (COVID-19)"},{"title3":"Compassionate use of remdesivir for patients with severe Covid-19"},{"title3":"Potential specific therapies in COVID-19"},{"title3":"Inflammation and thrombosis in COVID-19 pathophysiology: proteinase-activated and purinergic receptors as drivers and candidate therapeutic targets"},{"title3":"A human pluripotent stem cell-based model of SARS-CoV-2 infection reveals an ACE2-independent inflammatory activation of vascular endothelial cells through TLR4"},{"title3":"Dexamethasone in hospitalized patients with Covid-19"},{"title3":"Resistance of endothelial cells to SARS-CoV-2 infection in vitro Blerina Ahmetaj-Shala"},{"title3":"The serum of COVID-19 asymptomatic patients up-regulates proteins related to endothelial dysfunction and viral response in circulating angiogenic cells ex-vivo"},{"title3":"Evolving functions of endothelial cells in inflammation"},{"title3":"Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis"}]},{"title2":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses.","References":[{"title3":"Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus"},{"title3":"The molecular biology of coronaviruses"},{"title3":"Attachment of mouse hepatitis virus to O-acetylated sialic acid is mediated by hemagglutinin-esterase and not by the spike protein"},{"title3":"Rotavirus and coronavirus associated diarrhoea in domestic animals"},{"title3":"Coronavirus avian infectious bronchitis virus"},{"title3":"Detection of a group 2 coronavirus in dogs with canine infectious respiratory disease"},{"title3":"Pathogenesis of demyelination induced by a mouse hepatitis"},{"title3":"Transmissible gastroenteritis of swine: virus-intestinal cell interactions. II. Electron microscopy of the epithelium in isolated jejunal loops"},{"title3":"Transmissible gastroenteritis of swine: virus-intestinal cell interactions. I. Immunofluorescence, histopathology and virus production in the small intestine through the course of infection"},{"title3":"Replication of an enteric bovine coronavirus in intestinal organ cultures"},{"title3":"Pathogenicity studies of feline coronavirus isolates 79-1146 and 79-1683"},{"title3":"Recovery and Characterization of a Coronavirus from Military Dogs with Diarrhea"},{"title3":"Pathogenicity of turkey coronavirus in turkeys and chickens"},{"title3":"Recently discovered human coronaviruses"},{"title3":"Cultivation of a novel type of common-cold virus in organ cultures"},{"title3":"Genomic analysis of 15 human coronaviruses OC43 (HCoV-OC43s) circulating in France from 2001 to 2013 reveals a high intra-specific diversity with new recombinant genotypes"},{"title3":"Medical reviews. Coronaviruses"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"MERS: emergence of a novel human coronavirus"},{"title3":"Coronavirus infections in working adults. Eight-year study with 229 E and OC 43"},{"title3":"Human coronavirus NL63 infection and other coronavirus infections in children hospitalized with acute respiratory disease in Hong Kong"},{"title3":"A new virus isolated from the human respiratory tract"},{"title3":"Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease"},{"title3":"Signs and symptoms in common colds"},{"title3":"Human coronavirus NL63, a new respiratory virus"},{"title3":"A previously undescribed coronavirus associated with respiratory disease in humans"},{"title3":"Evidence of a novel human coronavirus that is associated with respiratory tract disease in infants and young children"},{"title3":"Understanding human coronavirus HCoV-NL63"},{"title3":"Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia"},{"title3":"More and more coronaviruses: human coronavirus HKU1"},{"title3":"Clinical and molecular epidemiological features of coronavirus HKU1-associated community-acquired pneumonia"},{"title3":"Coronavirus HKU1 and other coronavirus infections in Hong Kong"},{"title3":"Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method"},{"title3":"Coronavirus HKU1 infection in the United States"},{"title3":"Evidence of human coronavirus HKU1 and human bocavirus in Australian children"},{"title3":"Detection of the new human coronavirus HKU1: a report of 6 cases"},{"title3":"Coronavirus HKU1 in children, Brazil, 1995"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Middle East respiratory syndrome"},{"title3":"Middle East respiratory syndrome coronavirus: a case-control study of hospitalized patients"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection"},{"title3":"MERS in South Korea and China: a potential outbreak threat?"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Identification of a novel coronavirus in bats"},{"title3":"Coronaviruses post-SARS: update on replication and pathogenesis"},{"title3":"Antibodies to SARS coronavirus in civets"},{"title3":"Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms"},{"title3":"Ecoepidemiology and complete genome comparison of different strains of severe acute respiratory syndrome-related Rhinolophus bat coronavirus in China reveal bats as a reservoir for acute, self-limiting infection that allows recombination events"},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"ORF8-related genetic evidence for Chinese horseshoe bats as the source of human severe acute respiratory syndrome coronavirus"},{"title3":"Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study"},{"title3":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease"},{"title3":"MERS coronavirus in dromedary camel herd, Saudi Arabia"},{"title3":"Isolation of MERS coronavirus from a dromedary camel, Qatar, 2014"},{"title3":"MERS coronaviruses in dromedary camels, Egypt"},{"title3":"Concerns about misinterpretation of recent scientific data implicating dromedary camels in epidemiology of Middle East respiratory syndrome (MERS)"},{"title3":"Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26"},{"title3":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26"},{"title3":"Co-circulation of three camel coronavirus species and recombination of MERS-CoVs in Saudi Arabia"},{"title3":"Mosaic structure of human coronavirus NL63, one thousand years of evolution"},{"title3":"Does IBV change slowly despite the capacity of the spike protein to vary greatly?"},{"title3":"Genetic drift of human coronavirus OC43 spike gene during adaptive evolution"},{"title3":"Moderate mutation rate in the SARS coronavirus genome and its implications"},{"title3":"Spread, circulation, and evolution of the Middle East respiratory syndrome coronavirus"},{"title3":"Coronavirus diversity, phylogeny and interspecies jumping"},{"title3":"Infectious diseases emerging from Chinese wet-markets: zoonotic origins of severe respiratory viral infections"},{"title3":"Comparative analysis of 22 coronavirus HKU1 genomes reveals a novel genotype and evidence of natural recombination in coronavirus HKU1"},{"title3":"Recombination between nonsegmented RNA genomes of murine coronaviruses"},{"title3":"Evidence of recombinant strains of porcine epidemic diarrhea virus, United States, 2013"},{"title3":"Emergence of pathogenic coronaviruses in cats by homologous recombination between feline and canine coronaviruses"},{"title3":"Recombinant canine coronaviruses related to transmissible gastroenteritis virus of Swine are circulating in dogs"},{"title3":"Molecular epidemiology of human coronavirus OC43 reveals evolution of different genotypes over time and recent emergence of a novel genotype due to natural recombination"},{"title3":"Genotype shift in human coronavirus OC43 and emergence of a novel genotype by natural recombination"},{"title3":"Phylogenetic and recombination analysis of coronavirus HKU1, a novel coronavirus from patients with pneumonia"},{"title3":"Evidence from the evolutionary analysis of nucleotide sequences for a recombinant history of SARS-CoV"},{"title3":"Testing the hypothesis of a recombinant origin of the SARS-associated coronavirus"},{"title3":"Origin and possible genetic recombination of the Middle East respiratory syndrome coronavirus from the first imported case in China: phylogenetics and coalescence analysis"},{"title3":"Coronavirus 229E-related pneumonia in immunocompromised patients"},{"title3":"Coronaviruses in children, Greece"},{"title3":"Epidemiological and clinical features of human coronavirus infections among different subsets of patients"},{"title3":"Isolation and characterization of current human coronavirus strains in primary human epithelial cell cultures reveal differences in target cell tropism"},{"title3":"Severe Acute Respiratory Syndrome (SARS)"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"A novel pancoronavirus RT-PCR assay: frequent detection of human coronavirus NL63 in children hospitalized with respiratory tract infections in Belgium"},{"title3":"Human coronavirus NL63 infection in Canada"},{"title3":"Croup is associated with the novel coronavirus NL63"},{"title3":"Human coronavirus NL63 infection and other coronavirus infections in children hospitalized with acute respiratory disease in Hong Kong, China"},{"title3":"The common cold: a review of the literature"},{"title3":"Detection of viruses identified recently in children with acute wheezing"},{"title3":"State of knowledge and data gaps of Middle East respiratory syndrome coronavirus (MERS-CoV) in humans"},{"title3":"Viral Shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection"}]},{"title2":"Origin and evolution of pathogenic coronaviruses.","References":[{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Severe Acute Respiratory Syndrome (SARS) coronavirus ORF8 protein is acquired from SARS-related coronavirus from greater horseshoe bats through recombination"},{"title3":"SARS-CoV-2 and COVID-19: the most important research questions"},{"title3":"New insights into the mechanisms of RNA recombination"},{"title3":"Generation of coronavirus spike deletion variants by high-frequency recombination at regions of predicted RNA secondary structure"},{"title3":"RNA recombination in animal and plant viruses"},{"title3":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses"},{"title3":"Adaptive evolution of MERS-CoV to species variation in DPP4"},{"title3":"Bats and coronaviruses"}]},{"title2":"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003.","References":[{"title3":"Epidemiological study on severe acute respiratory syndrome in Guangdong province"},{"title3":"Guangdong Public Health Office. 2003: Document No 2. Summary report of investigating an atypical pneumonia outbreak in Zhongshan (January 21, 2003)."},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Update: outbreak of severe acute respiratory syndrome-Worldwide, 2003"},{"title3":"Severe acute respiratory syndrome (SARS)"},{"title3":"Cumulative number of reported probable cases of severe acute respiratory syndrome (SARS)"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Case definitions for surveillance of severe acute respiratory syndrome (SARS)"},{"title3":"The Genome sequence of the SARS-associated coronavirus"},{"title3":"Emergence of multiple genotypes of H5N1 avian influenza viruses in Hong Kong SAR"},{"title3":"MEGA2: molecular evolutionary genetics analysis software"},{"title3":"Quantitation of relative fitness and great adaptability of clonal populations of RNA viruses"},{"title3":"RNA virus mutations and fitness for survival"},{"title3":"A pandemic warning?"},{"title3":"Characterisation of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness"},{"title3":"An influenza epicentre?"}]},{"title2":"A novel coronavirus associated with severe acute respiratory syndrome.","References":[{"title3":"Ahmadi KS, Vahabizad F, Banihashemi G, Sahraian MA,  Gheini MR, Eslami M, Marhamati H, Mirhadi MS (2020) Ischemic stroke in patients with COVID-19 disease: a report of 10 cases from Iran Cerebrovasc Dis 1-6 10.1159/000513279"},{"title3":"Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19"},{"title3":"COVID-19 infection recurrence presenting with meningoencephalitis"},{"title3":"Matos AR, Quintas-Neves M, Oliveira AI, Dias L, Marques S, Carvalho R, Alves JN (2020) COVID-19 associated central nervous system vasculopathy Can J Neurol Sci 1-6 10.1017/cjn.2020.1092020.1092020.1092020.109"},{"title3":"Focal cerebral arteriopathy in a COVID-19 pediatric patient"},{"title3":"An updated review of the association of host genetic factors with susceptibility and resistance to COVID-19"},{"title3":"A first case of meningitis/encephalitis associated with SARS-Coronavirus-2"},{"title3":"COVID-19, SARS and MERS: a neurological perspective"},{"title3":"Frontier therapeutics and vaccine strategies for sars-cov-2 (COVID-19): a review"},{"title3":"A review of Coronavirus Disease-2019 (COVID-19)"},{"title3":"Neurological manifestations in severe acute respiratory syndrome"},{"title3":"Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, Liu C, Yang C (2020) Nervous system involvement after infection with COVID-19 and other coronaviruses Brain Behav Immun 18-22 10.1016/j.bbi.2020.03.0312020.03.0312020.03.0312020.03.031"},{"title3":"Encephalitis as a clinical manifestation of COVID-19"},{"title3":"Mild encephalitis/encephalopathy with reversible splenial lesion (MERS) in adults-a case report and literature review"}]},{"title2":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome.","References":[]},{"title2":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia.","References":[]},{"title2":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease.","References":[{"title3":"Emergence of Zaire Ebola virus disease in Guinea"},{"title3":"Progress in global surveillance and response capacity 10 years after severe acute respiratory syndrome"},{"title3":"Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015"},{"title3":"Infection with MERS-CoV causes lethal pneumonia in the common marmoset"},{"title3":"Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak"},{"title3":"Outbreak of tuberculosis among regular patrons of a neighborhood bar"},{"title3":"Cynomolgus macaque as an animal model for severe acute respiratory syndrome"},{"title3":"Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys"},{"title3":"Explosive school-based measles outbreak: intense exposure may have resulted in high risk, even among revaccinees"},{"title3":"Promedmail.org (2015). MERS-COV (97): South Korea, Saudi Arabia. International Society for Infectious Diseases."},{"title3":"Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions"},{"title3":"MERS in South Korea and China: a potential outbreak threat?"},{"title3":"WHO (2015a). Middle East respiratory syndrome coronavirus (MERS-CoV) - Republic of Korea. Disease Outbreak News. 24 May 2015. http://www.who.int/csr/don/24-may-2015-mers-korea/en/."},{"title3":"WHO (2015b). Sierra Leone: a traditional healer and a funeral. http://www.who.int/csr/disease/ebola/ebola-6-months/sierra-leone/en/."},{"title3":"Ebola virus transmission in guinea pigs"}]},{"title2":"Viral and bacterial etiology of acute febrile respiratory syndrome among patients in Qinghai, China.","References":[{"title3":"Prevalence and Seasonal Distribution of Respiratory Viruses During the 2014 - 2015 Season in Istanbul"},{"title3":"the top 10 global causes of deaths"},{"title3":"Viral etiology of influenza-like illnesses in Cameroon, January-December 2009"},{"title3":"Screening of respiratory pathogens by Respiratory Multi Well System (MWS) r-gene assay in hospitalized patients"},{"title3":"Comparison of three multiplex PCR assays for the detection of respiratory viral infections: evaluation of xTAG respiratory virus panel fast assay, RespiFinder 19 assay and RespiFinder SMART 22 assay"},{"title3":"Comparison of two commercial molecular assays for simultaneous detection of respiratory viruses in clinical samples using two automatic electrophoresis detection systems"},{"title3":"Mixed respiratory virus infections"},{"title3":"Prospective evaluation of a novel multiplex real-time PCR assay for detection of fifteen respiratory pathogens-duration of symptoms significantly affects detection rate"},{"title3":"Comparison of the prevalence of respiratory viruses in patients with acute respiratory infections at different hospital settings in North China, 2012-2015"},{"title3":"Detection of six common human paramyxoviruses in patients with acute febrile respiratory symptoms using a novel multiplex real-time RT-PCR assay"},{"title3":"Two-tube multiplex real-time reverse transcription PCR to detect six human coronaviruses"},{"title3":"The current epidemiology and clinical decisions surrounding acute respiratory infections"},{"title3":"Comparative evaluation of six commercialized multiplex PCR kits for the diagnosis of respiratory infections"},{"title3":"Seeking the source of Pseudomonas aeruginosa infections in a recently opened hospital: an observational study using whole-genome sequencing"},{"title3":"Detection of pathogens by real-time PCR in adult patients with acute exacerbation of bronchial asthma"},{"title3":"The Clinical Significance of FilmArray Respiratory Panel in Diagnosing Community-Acquired Pneumonia"},{"title3":"Evaluation of Anyplex II RV16 and RB5 real-time RT-PCR compared to Seeplex (R) RV15 OneStep ACE and PneumoBacter ACE for the simultaneous detection of upper respiratory pathogens"},{"title3":"Aetiology of Acute Respiratory Tract Infections in Hospitalised Children in Cyprus"},{"title3":"Viral etiologies of acute respiratory infections among hospitalized Vietnamese children in Ho Chi Minh City, 2004-2008"},{"title3":"Multiplex real-time PCR for detection of respiratory tract infections"},{"title3":"Surveillance of acute respiratory infections among outpatients: A pilot study in Isfahan city"},{"title3":"Prevalence and seasonal distribution of respiratory viruses in patients with acute respiratory tract infections, 2002-2014"},{"title3":"Common viral etiologies of community acquired lower respiratory tract infections in young children and their relationship with long term complications"},{"title3":"New Epidemiological and Clinical Signatures of 18 Pathogens from Respiratory Tract Infections Based on a 5-Year Study"},{"title3":"Molecular typing and epidemiology profiles of human adenovirus infection among paediatric patients with severe acute respiratory infection in China"},{"title3":"Epidemiologic differences of four major respiratory viruses between children, adolescents, and adults in Korea"},{"title3":"A previously undescribed coronavirus associated with respiratory disease in humans"},{"title3":"Epidemiology of acute respiratory infections in children in Guangzhou: a three-year study"},{"title3":"Newly identified respiratory viruses associated with acute lower respiratory tract infections in children in Lanzou, China, from 2006 to 2009"},{"title3":"Human parainfluenza virus infection in severe acute respiratory infection cases in Beijing, 2014-2016: A molecular epidemiological study"},{"title3":"Molecular Characterization of Human Respiratory Syncytial Virus in the Philippines, 2012-2013"},{"title3":"Single and multiple respiratory virus infections and severity of respiratory disease: a systematic review"},{"title3":"Epidemiology characteristics of respiratory viruses found in children and adults with respiratory tract infections in southern China"},{"title3":"Frequent detection of respiratory viruses without symptoms: toward defining clinically relevant cutoff values"}]},{"title2":"Coronaviruses and the human airway: a universal system for virus-host interaction studies.","References":[{"title3":"Coronaviruses: an overview of their replication and pathogenesis"},{"title3":"Coronavirus genome structure and replication"},{"title3":"The Genome Organization of the Nidovirales: Similarities and Differences between Arteri-, Toro-, and Coronaviruses"},{"title3":"A new coronavirus-like particle associated with diarrhea in swine"},{"title3":"A nomenclature for avian coronavirus isolates and the question of species status"},{"title3":"Enteric disease in postweaned beef calves associated with Bovine coronavirus clade 2"},{"title3":"Cleavage of a Neuroinvasive Human Respiratory Virus Spike Glycoprotein by Proprotein Convertases Modulates Neurovirulence and Virus Spread within the Central Nervous System"},{"title3":"The chemokine receptor CXCR2 and coronavirus-induced neurologic disease"},{"title3":"Acute hepatic failure in IFN-gamma-deficient BALB/c mice after murine coronavirus infection"},{"title3":"Felten S, Weider K, Doenges S, Gruendl S, Matiasek K, Hermanns W, et al. Detection of feline coronavirus spike gene mutations as a tool to diagnose feline infectious peritonitis. J Feline Med Surg. 2015."},{"title3":"A new virus isolated from the human respiratory tract"},{"title3":"Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. http://www.who.int/csr/sars/country/table2004_04_21/en/. Accessed 7 Dec 2015."},{"title3":"Identification of a new human coronavirus"},{"title3":"Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Middle East Respiratory Syndrome Coronavirus Outbreak in the Republic of Korea, 2015"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV). http://www.who.int/emergencies/mers-cov/en/. Accessed 7 Dec 2015."},{"title3":"Effects of a &quot;new&quot; human respiratory virus in volunteers"},{"title3":"Enzyme-linked immunosorbent assay for detection of antibody in volunteers experimentally infected with human coronavirus strain 229 E"},{"title3":"The behaviour of recent isolates of human respiratory coronavirus in vitro and in volunteers: evidence of heterogeneity among 229E-related strains"},{"title3":"The &quot;common cold&quot; in frail older persons: impact of rhinovirus and coronavirus in a senior daycare center"},{"title3":"Human coronavirus 229E infects polarized airway epithelia from the apical surface"},{"title3":"Culturing the unculturable: human coronavirus HKU1 infects, replicates, and produces progeny virions in human ciliated airway epithelial cell cultures"},{"title3":"Human Coronavirus-Associated Influenza-Like Illness in the Community Setting in Peru"},{"title3":"High incidence but low burden of coronaviruses and preferential associations between respiratory viruses"},{"title3":"The pediatric burden of human coronaviruses evaluated for twenty years"},{"title3":"Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS"},{"title3":"Evidence supporting a zoonotic origin of human coronavirus strain NL63"},{"title3":"Evidence for an Ancestral Association of Human Coronavirus 229E with Bats"},{"title3":"Estimating the risk of Middle East respiratory syndrome (MERS) death during the course of the outbreak in the Republic of Korea, 2015"},{"title3":"The emergence of the Middle East Respiratory Syndrome coronavirus (MERS-CoV)"},{"title3":"ORF8-Related Genetic Evidence for Chinese Horseshoe Bats as the Source of Human Severe Acute Respiratory Syndrome Coronavirus"},{"title3":"Identification of diverse alphacoronaviruses and genomic characterization of a novel severe acute respiratory syndrome-like coronavirus from bats in China"},{"title3":"Novel SARS-like betacoronaviruses in bats, China, 2011"},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"Menachery VD, Yount Jr BL, Debbink K, Agnihothram S, Gralinski LE, Plante JA, et al. A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence. Nat Med. 2015."},{"title3":"Rooting the phylogenetic tree of middle East respiratory syndrome coronavirus by characterization of a conspecific virus from an African bat"},{"title3":"Spread, circulation, and evolution of the Middle East respiratory syndrome coronavirus"},{"title3":"Ready, set, fuse! The coronavirus spike protein and acquisition of fusion competence"},{"title3":"Membrane ectopeptidases targeted by human coronaviruses"},{"title3":"TMPRSS2 activates the human coronavirus 229E for cathepsin-independent host cell entry and is expressed in viral target cells in the respiratory epithelium"},{"title3":"Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response"},{"title3":"Human aminopeptidase N is a receptor for human coronavirus 229E"},{"title3":"Expression of aminopeptidase N and dipeptidyl peptidase IV in the healthy and asthmatic bronchus"},{"title3":"Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human Angiotensin-converting enzyme 2 virus receptor"},{"title3":"Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV"},{"title3":"Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures"},{"title3":"Human Coronavirus HKU1 Spike Protein Uses O-Acetylated Sialic Acid as an Attachment Receptor Determinant and Employs Hemagglutinin-Esterase Protein as a Receptor-Destroying Enzyme"},{"title3":"Analysis of cellular receptors for human coronavirus OC43"},{"title3":"Isolation and characterization of current human coronavirus strains in primary human epithelial cell cultures reveal differences in target cell tropism"},{"title3":"Efficient replication of the novel human betacoronavirus EMC on primary human epithelium highlights its zoonotic potential"},{"title3":"Infectious RNA transcribed in vitro from a cDNA copy of the human coronavirus genome cloned in vaccinia virus"},{"title3":"Recovery of a neurovirulent human coronavirus OC43 from an infectious cDNA clone"},{"title3":"Systematic assembly of a full-length infectious clone of human coronavirus NL63"},{"title3":"Animal models for the study of influenza pathogenesis and therapy"},{"title3":"Animal models for SARS and MERS coronaviruses"},{"title3":"Development of a transgenic mouse model susceptible to human coronavirus 229E"},{"title3":"Cells of human aminopeptidase N (CD13) transgenic mice are infected by human coronavirus-229E in vitro, but not in vivo"},{"title3":"Rapid generation of a mouse model for Middle East respiratory syndrome"},{"title3":"Generation of a transgenic mouse model of Middle East respiratory syndrome coronavirus infection and disease"},{"title3":"Human parainfluenza virus serotypes differ in their kinetics of replication and cytokine secretion in human tracheobronchial airway epithelium"},{"title3":"Human bocavirus 1 infects commercially available primary human airway epithelium cultures productively"},{"title3":"Infection of human airway epithelium by human and avian strains of influenza a virus"},{"title3":"Human bocavirus can be cultured in differentiated human airway epithelial cells"},{"title3":"Non-animal models of epithelial barriers (skin, intestine and lung) in research, industrial applications and regulatory toxicology"},{"title3":"Airway epithelial cells: current concepts and challenges"},{"title3":"Alveolar development and disease"},{"title3":"Building and maintaining the epithelium of the lung"},{"title3":"Serial culturing of human bronchial epithelial cells derived from biopsies"},{"title3":"Ciliogenesis in human bronchial epithelial cells cultured at the air-liquid interface"},{"title3":"The air-liquid interface and use of primary cell cultures are important to recapitulate the transcriptional profile of in vivo airway epithelia"},{"title3":"Bilateral entry and release of Middle East respiratory syndrome coronavirus induces profound apoptosis of human bronchial epithelial cells"},{"title3":"Innate immune response of human alveolar type II cells infected with severe acute respiratory syndrome-coronavirus"},{"title3":"Human coronavirus HKU1 infection of primary human type II alveolar epithelial cells: cytopathic effects and innate immune response"},{"title3":"Anggakusuma, Dijkman R, Gad HH, et al.: Transcriptome analysis reveals a classical interferon signature induced by IFNlambda4 in human primary cells"},{"title3":"SARS-coronavirus replication/transcription complexes are membrane-protected and need a host factor for activity in vitro"},{"title3":"SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum"},{"title3":"2'-O methylation of the viral mRNA cap evades host restriction by IFIT family members"},{"title3":"Ribose 2'-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5"},{"title3":"Middle east respiratory syndrome coronavirus 4a protein is a double-stranded RNA-binding protein that suppresses PACT-induced activation of RIG-I and MDA5 in the innate antiviral response"},{"title3":"Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist"},{"title3":"The ORF4b-encoded accessory proteins of Middle East respiratory syndrome coronavirus and two related bat coronaviruses localize to the nucleus and inhibit innate immune signalling"},{"title3":"Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists"},{"title3":"Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane"},{"title3":"Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice"},{"title3":"Protective efficacy of recombinant modified vaccinia virus Ankara delivering Middle East respiratory syndrome coronavirus spike glycoprotein"},{"title3":"Al-Tawfiq JA, Momattin H, Dib J, Memish ZA. Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study. Int J Infect Dis. 20:42-6."},{"title3":"Zumla A, Azhar EI, Arabi Y, Alotaibi B, Rao M, McCloskey B, et al. Host-directed therapies for improving poor treatment outcomes associated with the middle east respiratory syndrome coronavirus infections. Int J Infect Dis. 40:71-4."},{"title3":"Omrani AS, Saad MM, Baig K, Bahloul A, Abdul-Matin M, Alaidaroos AY, et al. Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study. Lancet Infect Dis. 14:1090-5."},{"title3":"IFN-alpha2a or IFN-beta1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study"},{"title3":"Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry"},{"title3":"Proteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research"},{"title3":"The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds"},{"title3":"The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors"},{"title3":"Targeting membrane-bound viral RNA synthesis reveals potent inhibition of diverse coronaviruses including the Middle East respiratory syndrome virus"},{"title3":"Novel polymeric inhibitors of HCoV-NL63"},{"title3":"Isolation from man of &quot;avian infectious bronchitis virus-like&quot; viruses (coronaviruses) similar to 229E virus, with some epidemiological observations"},{"title3":"Human coronavirus 229E: receptor binding domain and neutralization by soluble receptor at 37 degrees C"},{"title3":"Growth in suckling-mouse brain of &quot;IBV-like&quot; viruses from patients with upper respiratory tract disease"},{"title3":"The SARS-CoV S glycoprotein: expression and functional characterization"},{"title3":"Identification of residues in the receptor-binding domain (RBD) of the spike protein of human coronavirus NL63 that are critical for the RBD-ACE2 receptor interaction"},{"title3":"The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies"},{"title3":"SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium"},{"title3":"Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus"},{"title3":"Dipeptidyl peptidase 4 distribution in the human respiratory tract: implications for the Middle East respiratory syndrome"}]},{"title2":"A new arenavirus in a cluster of fatal transplant-associated diseases.","References":[]},{"title2":"A novel coronavirus genome identified in a cluster of pneumonia cases : Wuhan, China 2019-2020.","References":[{"title3":"From &quot;A&quot;IV to &quot;Z&quot;IKV: attacks from emerging and Re-emerging  pathogens"},{"title3":"MAFFT multiple sequence alignment software version 7: improvements in performance and usability"},{"title3":"A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood"}]},{"title2":"Pathogen genomics in public health.","References":[]}]},{"title1":"SARS-CoV-2 Infection in Children","References":[{"title2":". Coronavirus disease 2019 (COVID-19): situation report : 50 ().","References":[]},{"title2":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention.","References":[]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China.","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":". Country &amp; technical guidance : coronavirus disease (COVID-19) ().","References":[]}]},{"title1":"Systematic review of COVID?19 in children shows milder cases and a better prognosis than adults","References":[{"title2":"A Novel Coronavirus from Patients with Pneumonia in China, 2019","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"2019 novel coronavirus (2019-nCoV) outbreak: a new challenge"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus phylogeny: toward consensus"},{"title3":"Diagnosis and treatment of new coronavirus pneumonia (trial version 7) [J / OL]. Tianjin J Tradit Chin Med. 2020;1-5. http://kns.cnki.net/kcms/detail/12.1349.R.20200304.1638.006.html. Accessed 3 June 2020."},{"title3":"Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus"},{"title3":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV"},{"title3":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients"},{"title3":"Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study"},{"title3":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early"},{"title3":"Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Human ipsc-derived cardiomyocytes are susceptible to Sars-Cov-2 infection"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"}]},{"title2":"An interactive web-based dashboard to track COVID-19 in real time","References":[{"title3":"WHO statement regarding cluster of pneumonia cases in Wuhan, China"},{"title3":"Coronavirus disease 2019 (COVID-19) situation reports"},{"title3":"Tracking the epidemic"}]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","References":[{"title3":"The 2019-nCoV Outbreak Joint Field Epidemiology Investigation Team, Li Q. Notes from the field: an outbreak of NCIP (2019-nCoV) infection in China : Wuhan, Hubei Province, 2019-2020."},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases : Wuhan, China 2019-2020."},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Use of national pneumonia surveillance to describe influenza A(H7N9) virus epidemiology, China, 2004-2013."},{"title3":"A novel coronavirus emerging in China : key questions for impact assessment."},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus."},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome."},{"title3":"Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future."},{"title3":"Coronavirus infections : more than just the common cold."},{"title3":"Another decade, another coronavirus."},{"title3":"SARS and MERS: recent insights into emerging coronaviruses."},{"title3":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at January 2020."},{"title3":"How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count."}]},{"title2":"COVID-19 in children: initial characterization of the pediatric disease","References":[]},{"title2":"Persons evaluated for 2019 novel coronavirus - United States, January 2020","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak:United States, December 31, 2019-February 4, 2020."},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam."}]},{"title2":"A Case Series of children with 2019 novel coronavirus infection: clinical and epidemiological features","References":[]},{"title2":"SARS-CoV-2 infection in children: Transmission dynamics and clinical characteristics","References":[]},{"title2":"2019-nCoV: polite with children!","References":[{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia"},{"title3":"Severe acute respiratory syndrome in children"},{"title3":"The Middle East Respiratory Syndrome Coronavirus - A Continuing Risk to Global Health Security"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Innate Immune Evasion by Human Respiratory RNA Viruses"},{"title3":"Coronavirus Infections and Immune Responses"}]},{"title2":"Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Notice on prevention and control of pneumonia in children and pregnant women with new coronavirus infection"},{"title3":"New coronavirus pneumonia prevention and control program (4th edn)"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Interim guidance"},{"title3":"Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases. Interim guidance"},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR"},{"title3":"The Spanish flu in Iceland 1918. Lessons in medicine and history"},{"title3":"H1N1 2009 influenza virus infection during pregnancy in the USA"},{"title3":"Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome"},{"title3":"Coronavirus envelope protein: current knowledge"},{"title3":"Novel 2019 coronavirus genome"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Infants born to mothers with severe acute respiratory syndrome"},{"title3":"Rubella and pregnancy: diagnosis, management and outcomes"},{"title3":"Wuhan Tongji Hospital diagnoses first case of neonatal infection with new coronavirus"},{"title3":"Neonatal coronavirus expert confirmed at 30 hours of birth: vertical transmission from mother to infant"}]},{"title2":"New coronavirus: new challenges for pediatricians","References":[{"title3":"National Recommendations for Diagnosis and Treatment of pneumonia caused by 2019-nCoV (the 4th edition). National Health Commission and National Administrative Office of Chinese Traditional Medicine. https://www.nhc.gov.cn/xcs/zhengcwj/202001/4294563ed35b43209b31739bd0785e67/files/7a9309111267475a99d4306962c8bf78.pdf. Access 29 Jan 2020."},{"title3":"Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus"}]},{"title2":"Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"National Recommendations for Diagnosis and Treatment of pneumonia caused by 2019-nCoV (the 4th edition). National Health Commission and National Administrative Office of Chinese Tradition Medicine. https://www.nhc.gov.cn/xcs/zhengcwj/202001/4294563ed35b43209b31739bd0785e67/files/7a9309111267475a99d4306962c8bf78.pdf. Access 29 Jan 2020."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Another decade, another coronavirus"},{"title3":"Diangosis and treatment guideline of community acquired pneumonia in children"},{"title3":"Role of Lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Treatment of Middle East respiratory syndrome with a combination of lopinavir-ritonavir and interferon-beta1b (MIRACLE trial): study protocol for a randomized controlled trial"},{"title3":"Expert consensus on the diagnosis and treatment of viral pneumonia in children (2019)"},{"title3":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome"},{"title3":"WHO. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Jan 11, 2020. https://www.who.int/docs/default-source/coronaviruse/clinical-management-of-novel-cov.pdf?sfvrsn=bc7da517_2. Accessed 30 Jan 30 2020."},{"title3":"Diagnosis and treatment guideline of community acquired pneumonia in children (2013 the First part)"},{"title3":"Guidelines for the diagnosis and treatment of adenovirus pneumonia in children (2019 edition)"},{"title3":"Consensus of extracorporeal membrane oxygenation support for acute fulminant myocarditis in children"}]},{"title2":"A 55-Day-Old Female Infant infected with COVID 19: presenting with pneumonia, liver injury, and heart damage","References":[]},{"title2":"Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China","References":[]},{"title2":"The coronavirus disease 2019 (COVID-19)","References":[]},{"title2":"The transmission and diagnosis of 2019 novel coronavirus infection disease (COVID-19): a Chinese perspective","References":[{"title3":"Wuhan seafood market may not be source of novel virus spreading globally"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan"},{"title3":"A man was infected by contacting with a confirmed patient for 15 seconds without a mask"},{"title3":"A man was infected by contacting with a confirmed patient for 50 seconds without a mask"},{"title3":"[The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]"},{"title3":"14 key questions and answers"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"},{"title3":"[An update on the epidemiological characteristics of novel coronavirus pneumonia COVID-19]"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Environmental contamination and viral shedding in MERS patients during MERS-CoV Outbreak in South Korea"},{"title3":"2019-nCoV was found in the house of the confirmed patient"},{"title3":"The 19th news conference on epidemic prevention and control of Guangdong Province"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"First data on stability and resistance of SARS coronavirus compiled by members of WHO laboratory network"},{"title3":"Critical care lessons from severe acute respiratory syndrome"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Enteric involvement of coronaviruses: is faecal-oral transmission of SARS-CoV-2 possible?"},{"title3":"Structure analysis of the receptor binding of 2019-nCoV"},{"title3":"2019-nCoV transmission through the ocular surface must not be ignored"},{"title3":"Peking University Hospital Wang Guangfa disclosed how he was infected"},{"title3":"The notice of launching guideline on diagnosis and treatment of COVID-19"},{"title3":"Return of the coronavirus: 2019-nCoV"},{"title3":"Clinical and epidemiologic characteristics of spreaders of Middle East respiratory syndrome coronavirus during the 2015 outbreak in Korea"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Scientists are racing to model the next moves of a coronavirus that's still hard to predict"},{"title3":"Asymptomatic SARS coronavirus infection among healthcare workers, Singapore"},{"title3":"2014 MERS-CoV outbreak in Jeddah:a link to health care facilities"},{"title3":"Transmission of 2019-nCoV Infection from an asymptomatic contact in Germany"},{"title3":"Infectivity of an asymptomatic patient with Middle East respiratory syndrome coronavirus infection"},{"title3":"Zhang Wenhong, leader of Shanghai medical treatment expert panel: Asymptomatic infected patients will not become super-spreaders"},{"title3":"Interview with Qiao Jie, Chinese Academy of Engineering academicians, member of the national medical team of Hubei Province"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome"},{"title3":"MERS-CoV infection in a pregnant woman in Korea"},{"title3":"Novel coronavirus infection in hospitalized infants under 1 year of age in China"},{"title3":"What are the risks of COVID-19 infection in pregnant women?"},{"title3":"Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records"},{"title3":"A confirmed patient had real-time RT-PCR detection before admission for three times, all negative for 2019-nCoV"},{"title3":"Interview with Peng Zhiyong, director of critical medicine department, Central South Hospital, Wuhan University"},{"title3":"Bulletin of 2019 novel coronavirus pneumonia from Wuhan Municipal Health Commission"},{"title3":"Bulletin of 2019 novel coronavirus pneumonia from Wuhan Municipal Health Commission"},{"title3":"The notice of launching guideline on diagnosis and treatment of the novel coronavirus pneumonia (NCP)"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"The notice of launching guideline on diagnosis and treatment of the novel coronavirus pneumonia (NCP)"}]},{"title2":"Laboratory abnormalities in children with novel coronavirus disease 2019","References":[{"title3":"Coronavirus Disease (COVID-19) Situation Reports"},{"title3":"Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China"},{"title3":"Laboratory abnormalities in children with novel coronavirus disease 2019"},{"title3":"[The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]"},{"title3":"Will children reveal their secret? The coronavirus dilemma"},{"title3":"Covid-19 in children: a brief overview after three months experience"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Epidemiologic and clinical characteristics of 10 children with coronavirus disease 2019 in Changsha, China"},{"title3":"Laboratory abnormalities in patients with COVID-2019 infection"},{"title3":"Laboratory abnormalities in children with mild and severe coronavirus disease 2019 (COVID-19): a pooled analysis and review"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China"},{"title3":"Considering BCG vaccination to reduce the impact of COVID-19"},{"title3":"SARS-CoV-2 Infection in Children"},{"title3":"Children with Covid-19 in pediatric emergency departments in Italy"}]},{"title2":"Clinical features of pediatric patients with COVID-19: a report of two family cluster cases","References":[{"title3":"Real-time reporting of 2019-nCoV outbreak. Xinhua news network. 2020. https://fms.news.cn/swf/2020_sjxw/2_1_xgyq/index.html. Accessed 28 Feb 2020."},{"title3":"Coronavirus latest: WHO officially names disease COVID-19. Nature. 2020. https://www.nature.com/articles/d41586-020-00154-w. Accessed 28 Feb 2020."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"CT imaging features of 2019 novel coronavirus (2019-nCoV)"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus disease (COVID-19) in China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"First case of severe childhood novel coronavirus pneumonia in China"},{"title3":"Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus"},{"title3":"Diagnosis and treatment of 2019 novel coronavirus infection in children: a pressing issue"}]},{"title2":"A well infant with coronavirus disease 2019 (COVID-19) with high viral load","References":[]},{"title2":"Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): facts and myths","References":[{"title3":"WHO. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200221-sitrep-32-covid-19.pdf?sfvrsn&amp;equals;4802d089_2. [Accessed on 21 February 2020]."},{"title3":"Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV"},{"title3":"2019 novel coronavirus disease (COVID-19) in Taiwan: reports of two cases from Wuhan, China"},{"title3":"A locally transmitted case of SARS-CoV-2 infection in Taiwan"},{"title3":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges"},{"title3":"Presumed asymptomatic carrier transmission of COVID-19"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"A familial cluster of infection associated with the 2019 novel coronavirus indicating potential person-to-person transmission during the incubation period"},{"title3":"Clinical characteristics of 2019 novel coronavirus infection in China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China"},{"title3":"An interim review of the epidemiological characteristics of 2019 novel coronavirus"},{"title3":"Initial cluster of novel coronavirus (2019-nCoV) infections in Wuhan, China is consistent with substantial human-to-human transmission"},{"title3":"Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020"},{"title3":"Protecting health-care workers from subclinical coronavirus infection"},{"title3":"Neutrophil-to-lymphocyte ratio predicts severe illness patients with 2019 novel coronaviruse in the early stage"},{"title3":"CT imaging features of 2019 novel coronavirus (2019-nCoV)"},{"title3":"CT Imaging of the 2019 novel coronavirus (2019-nCoV) pneumonia"},{"title3":"Imaging changes in patients with 2019-nCov"},{"title3":"Chest CT findings in 2019 novel coronavirus (2019-nCoV) infections from Wuhan, China: key points for the radiologist"},{"title3":"Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China"},{"title3":"Pre- and posttreatment chest CT findings: 2019 novel coronavirus (2019-nCoV) pneumonia"},{"title3":"Drug treatment options for the 2019-new coronavirus (2019-nCoV)"},{"title3":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro"},{"title3":"Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Arguments in favor of remdesivir for treating SARS-CoV-2 infections"},{"title3":"Chloroquine for the 2019 novel coronavirus"},{"title3":"Multicenter collaboration group of Department of Science and Technology of Guangdong Province and Health Commission of Guangdong Province for chloroquine in the treatment of novel coronavirus pneumonia. [Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia]"},{"title3":"Structure-activity relationship studies of lipophilic teicoplanin pseudoaglycon derivatives as new anti-influenza virus agents"},{"title3":"Glycopeptide antibiotics potently inhibit cathepsin L in the late endosome/lysosome and block the entry of Ebola virus, middle east respiratory syndrome coronavirus (MERS-CoV), and severe acute respiratory syndrome coronavirus (SARS-CoV)"},{"title3":"Inhibition of feline (FIPV) and human (SARS) coronavirus by semisynthetic derivatives of glycopeptide antibiotics"},{"title3":"Corticosteroid therapy for critically ill patients with middle east respiratory syndrome"},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients"},{"title3":"Factors associated with psychosis among patients with severe acute respiratory syndrome: a case-control study"},{"title3":"Glucocorticoid-induced diabetes in severe acute respiratory syndrome: the impact of high dosage and duration of methylprednisolone therapy"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"},{"title3":"Coronavirus infections and immune responses"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"2019-nCoV CDC Response Team. Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak - United States, December 31, 2019-February 4, 2020"},{"title3":"Controlling Middle East respiratory syndrome: lessons learned from severe acute respiratory syndrome"},{"title3":"Are children less susceptible to COVID-19?"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Are children less susceptible to COVID-19?","References":[]},{"title2":"Proposal for prevention and control of the 2019 novel coronavirus disease in newborn infants","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Facing the pandemic of 2019 novel coronavirus infections: the pediatric perspectives"},{"title3":"Infants born to mothers with severe acute respiratory syndrome"},{"title3":"Interim clinical guidance for management of patients with confirmed 2019 novel coronavirus (2019-nCoV) infection"}]},{"title2":"Chest computed tomography in children with COVID-19 respiratory infection","References":[{"title3":"World Health Organization (2020) Coronavirus disease (COVID-19) outbreak. https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed 15 Feb 2020"},{"title3":"World Health Organization (2020) Novel coronavirus : China. https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/. Accessed 15 Feb 2020"},{"title3":"International Committee on Taxonomy Viruses (2020) Naming the 2019 coronavirus. https://talk.ictvonline.org/. Accessed 15 Feb 2020"},{"title3":"World Health Organization (2020) Novel coronavirus (2019-nCoV) situation report - 22. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200211-sitrep-22-ncov.pdf?sfvrsn=fb6d49b1_2. Accessed 15 Feb 2020"},{"title3":"World Health Organization (2020) Novel coronavirus (COVID-19) situation. https://experience.arcgis.com/experience/685d0ace521648f8a5beeeee1b9125cd. Accessed 4 March 2020"},{"title3":"Chung M, Bernheim A, Mei XY et al (2020) CT imaging features of 2019 novel coronavirus (2019-nCoV). Radiology. 10.1148/radiol.2020200230. Accessed 20 Feb 2020"},{"title3":"Xie XZ, Zhong Z, Zhao W et al (2020) Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing. Radiology. 10.1148/radiol.2020200343. Accessed 20 Feb 2020"},{"title3":"Pan YY, Guan HX, Zhou SC et al (2020) Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China. Eur Radiol. 10.1007/s00330-020-06731-x. Accessed 20 Feb 2020"}]},{"title2":"Clinical and CT imaging features of the COVID-19 pneumonia: focus on pregnant women and children","References":[{"title3":"A Novel Coronavirus from Patients with Pneumonia in China, 2019"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"The International Committee on Taxonomy of Viruses (ICTV) Coronaviridae Study Group. Naming the 2019 Coronavirus. https://talk.ictvonline.org/."},{"title3":"Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. 2020;395(10223):514-523."},{"title3":"Importation and Human-to-Human Transmission of a Novel Coronavirus in Vietnam"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China"},{"title3":"National Health Commission of China. &quot;Report of the latest situation of novel coronavirus pneumonia in China as of February 18, 2020&quot;. http://www.nhc.gov.cn/xcs/yqtb/202002/8f2cfd17f4c040d89c69a4b29e99748c.shtml."},{"title3":"Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China"},{"title3":"Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia"},{"title3":"Clinical characteristics of 2019 novel coronavirus infection in China"},{"title3":"Chest CT for Typical 2019-nCoV Pneumonia: Relationship to Negative RT-PCR Testing"},{"title3":"Use of Chest CT in Combination with Negative RT-PCR Assay for the 2019 Novel Coronavirus but High Clinical Suspicion"},{"title3":"National Health Commission of China. &quot;Diagnosis and Treatment for COVID-19 Pneumonia (Fifth Trial Version)&quot;. http://www.nhc.gov.cn/."},{"title3":"Inflammation and pregnancy: the role of the immune system at the implantation site"},{"title3":"Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records"},{"title3":"Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia"},{"title3":"World Health Organization. Technical-guidance for 2019-nCoV RT-PCR. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/laboratory-guidance"},{"title3":"CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)"},{"title3":"Emerging Coronavirus 2019-nCoV Pneumonia"},{"title3":"Pulmonary sequelae in convalescent patients after severe acute respiratory syndrome: evaluation with thin-section CT"},{"title3":"Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases"},{"title3":"Protecting sensitive patient groups from imaging using ionizing radiation: effects during pregnancy, in fetal life and childhood"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Benign postpartum pleural effusion"},{"title3":"Radiographic and CT Features of Viral Pneumonia"},{"title3":"Time Course of Lung Changes On Chest CT During Recovery From 2019 Novel Coronavirus (COVID-19) Pneumonia"}]},{"title2":"Detection of COVID-19 in children in early January 2020 in Wuhan, China","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention."},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Defining the epidemiology of Covid-19 : studies needed."}]},{"title2":"Coronavirus disease (COVID-19) and neonate: what neonatologist need to know","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"A novel coronavirus outbreak of global health concern"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"  . Latest developments in epidemic control of 2019-nCoV."},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Genomic variance of the 2019-nCoV coronavirus"},{"title3":"Identification of 2019-nCoV related coronaviruses in Malayan pangolins in southern China"},{"title3":"  , National Adiministration of Traditional Chinese Medicine. Handbook of Prevention and Treatment of the Pneumonia Caused by the Novel Coronavirus (2019-nCoV) (Trial version 5)."},{"title3":"The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor2 ACE2 and the cellular protease TMPRSS2 for entry into target cells"},{"title3":"The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes"},{"title3":"Association of angiotensin-converting enzyme 2 gene polymorphism and enzymatic activity with essential hypertension in different gender: a case-control study"},{"title3":"Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov"},{"title3":"Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes"},{"title3":"Effects of coronavirus infections in children"},{"title3":"Middle East respiratory syndrome"},{"title3":"Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records"},{"title3":"The incubation period of 2019-nCoV from publicly reported confirmed cases: estimation and application"},{"title3":"Recommendation for the diagnosis and treatment of novel coronavirus infection/pneumonia in children in Hubei (Trial version 2)"},{"title3":"Severe acute respiratory syndrome (SARS) in neonates and children"},{"title3":"First case of neonate infected with novel coronavirus pneumonia in China"},{"title3":"First case of 2019 novel coronavirus infection in children in Shanghai"},{"title3":"Two cases of 2019 novel coronavirus infection in children"},{"title3":"2019 novel coronavirus (2019-nCoV) and 2019-nCoV pneumonia"},{"title3":"Efficient management of novel coronavirus pneumonia by efficient prevention and control in scientific manner"},{"title3":"Chinese expert consensus on the perinatal and neonatal management for the prevention and control of the 2019 novel coronavirus infection (First edition) Annals of Translational Medicine"},{"title3":"Chinese Journal of Pediatrics. Recommendations for the diagnosis, prevention and control of the 2019 novel coronavirus infection in children (first interim edition)"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Ribavirin and interferon-alpha2b as primary and preventive treatment for Middle East respiratory syndrome coronavirus: a preliminary report of two cases"},{"title3":"Early gene expression events in ferrets in response to SARS coronavirus infection versus direct interferon-alpha2b stimulation"},{"title3":"Network-based drug repurposing for human coronavirus"},{"title3":"The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis"}]},{"title2":"Management strategies of neonatal jaundice during the coronavirus disease 2019 outbreak","References":[{"title3":"Coronavirus investigating, and research team A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Clinical features of patients infected with novel coronavirus in Wuhan, China"},{"title3":"Diagnosis, treatment, and prevention of novel coronavirus infection in children: experts' consensus statement"},{"title3":"Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records"},{"title3":"Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia"},{"title3":"International perspectives: hyperbilirubinemia and kernicterus in neonates in China"},{"title3":"Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation"},{"title3":"Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns"},{"title3":"Use of a smartphone app to assess neonatal jaundice"},{"title3":"Evaluation of an automatic image-based screening technique for neonatal hyperbilirubinemia"},{"title3":"Chinese expert consensus on the perinatal and neonatal management for the prevention and control of the 2019 novel coronavirus infection (First edition)"}]},{"title2":"Coronavirus disease 2019 (COVID-19) and pregnancy: what obstetricians need to know","References":[]},{"title2":"The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak","References":[{"title3":"Pneumonia of unknown etiology in wuhan, China: potential for international spread via commercial air travel"},{"title3":"Outbreak of pneumonia of unknown etiology in wuhan China: the mystery and the miracle"},{"title3":"Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak"},{"title3":"Outbreak of a novel coronavirus"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Drug treatment options for the 2019-new coronavirus (2019-nCoV)"},{"title3":"Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China"},{"title3":"The extent of transmission of novel coronavirus in wuhan, China, 2020"},{"title3":"The Novel Chinese Coronavirus (2019-nCoV) Infections: challenges for fighting the storm"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Early transmission dynamics in wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Novel wuhan (2019-nCoV) coronavirus"},{"title3":"CT imaging of the 2019 novel coronavirus (2019-nCoV) pneumonia"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS"},{"title3":"Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020"},{"title3":"A tale of two viruses: the distinct spike glycoproteins of feline coronaviruses"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"A novel coronavirus from patients with pneumonia in China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia"},{"title3":"A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)"}]},{"title2":"An analysis of 38 pregnant women with COVID-19, their newborn infants, and maternal-fetal transmission of SARS-CoV-2: maternal coronavirus infections and pregnancy outcomes","References":[]},{"title2":"Potential maternal and infant outcomes from (Wuhan) coronavirus 2019-nCoV infecting pregnant women: lessons from SARS, MERS, and other human coronavirus infections","References":[{"title3":"Epidemic and emerging coronaviruses (severe acute respiratory syndrome and Middle East respiratory syndrome)"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Coronaviridae"},{"title3":"Another decade, another coronavirus"},{"title3":"Severe acute respiratory syndrome: Historical, epidemiologic, and clinical features"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Wuhan Seafood Market May Not Be Source of Novel Virus Spreading Globally"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Statement on the Second Meeting of the International Health Regulations (2005) Emergency Committee Regarding the Outbreak of Novel Coronavirus (2019-nCoV)"},{"title3":"Novel Coronavirus (2019-nCoV). Situation Report-20"},{"title3":"W.H.O. Declares Global Emergency as Wuhan Coronavirus Spreads"},{"title3":"Antepartum pneumonia in pregnancy"},{"title3":"Risk factors associated with the increasing prevalence of pneumonia during pregnancy"},{"title3":"Pneumonia during pregnancy: Has modern technology improved maternal and fetal outcome?"},{"title3":"Indirect obstetric deaths in the state of Michigan 1960-1968"},{"title3":"Pneumonia during pregnancy"},{"title3":"Emerging infections and pregnancy"},{"title3":"Immunobiologic adaptations of pregnancy"},{"title3":"Acute respiratory failure in pregnancy due to staphylococcal pneumonia"},{"title3":"Pregnancy and the lung"},{"title3":"Influenza occurring in pregnant women; a statistical study of thirteen hundred and fifty cases"},{"title3":"Observations on excess mortality associated with epidemic influenza"},{"title3":"Learning from SARS: Renewal of Public Health in Canada:SARS in Canada: Anatomy of an Outbreak"},{"title3":"Reporting Incidence of Severe Acute Respiratory Syndrome (SARS) Appendix A: Chronology"},{"title3":"Consensus Document on the Epidemiology of Severe Acute Respiratory Syndrome (SARS)"},{"title3":"Severe acute respiratory syndrome and pregnancy"},{"title3":"Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome"},{"title3":"Infection control for SARS in a tertiary neonatal centre"},{"title3":"SARS in newborns and children"},{"title3":"No. 225-Management guidelines for obstetric patients and neonates born to mothers with suspected or probable severe acute respiratory syndrome (SARS)"},{"title3":"A case-controlled study comparing clinical course and outcomes of pregnant and non-pregnant women with severe acute respiratory syndrome"},{"title3":"Clinical analysis of pregnancy in second and third trimesters complicated severe acute respiratory syndrome"},{"title3":"SARS and pregnancy: A case report"},{"title3":"SARS in pregnancy"},{"title3":"SARS during pregnancy, United States"},{"title3":"Severe acute respiratory syndrome in pregnancy"},{"title3":"Infants born to mothers with severe acute respiratory syndrome"},{"title3":"Severe acute respiratory syndrome (SARS) in neonates and children"},{"title3":"The placentas of patients with severe acute respiratory syndrome: A pathophysiological evaluation"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome"},{"title3":"The SARS epidemic in Hong Kong: What lessons have we learned?"},{"title3":"Management guidelines for obstetric patients and neonates born to mothers with suspected or probable severe acute respiratory syndrome (SARS)"},{"title3":"Middle East Respiratory Syndrome (MERS) Background"},{"title3":"Middle East respiratory syndrome coronavirus infection during pregnancy: A report of 5 cases from Saudi Arabia"},{"title3":"Middle East Respiratory Syndrome (MERS) Fact Sheet"},{"title3":"MERS-CoV infection in pregnant woman in Korea"},{"title3":"Middle East Respiratory Syndrome (MERS) Overview"},{"title3":"Family cluster of Middle East respiratory syndrome coronavirus infections"},{"title3":"Novel coronavirus infections in Jordan, April 2012: Epidemiological findings from a retrospective investigation"},{"title3":"2014 MERS-CoV outbreak in Jeddah:A link to health care facilities"},{"title3":"Transmission of Middle East respiratory syndrome coronavirus infections in healthcare settings, Abu Dhabi"},{"title3":"Middle East respiratory syndrome: What we learned from the 2015 outbreak in the Republic of Korea"},{"title3":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) origin and animal reservoir"},{"title3":"Dromedary camels and the transmission of Middle East respiratory syndrome coronavirus (MERS-CoV)"},{"title3":"Impact of Middle East respiratory syndrome coronavirus (MERS-CoV) on pregnancy and perinatal outcome"},{"title3":"An Overview of the latest infectious diseases around the world"},{"title3":"Middle East respiratory syndrome coronavirus during pregnancy, Abu Dhabi, United Arab Emirates 2013"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) infection during pregnancy: Report of two cases &amp; review of literature"},{"title3":"Stillbirth during infection with Middle East respiratory syndrome coronavirus"},{"title3":"Update on therapeutic options for Middle East respiratory syndrome coronavirus (MERS-CoV)"},{"title3":"Vertical transmission of human coronavirus. Prospective pilot study"},{"title3":"Materno-fetal transmission of human coronaviruses: A prospective pilot study"},{"title3":"Emerging respiratory viruses: Challenges and vaccine strategies"},{"title3":"Duration of antibody responses after severe acute respiratory syndrome"},{"title3":"Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus"},{"title3":"Clinical trials and administration of Zika virus vaccine in pregnant women: Lessons (that should have been) learned from excluding immunization with the Ebola vaccine during pregnancy and lactation"},{"title3":"Being pregnant during the Kivu Ebola virus outbreak in DR Congo: The rVSV-ZEBOV vaccine and its accessibility by mothers and infants during humanitarian crises and in conflict areas"},{"title3":"Maternal and infant death and the rVSV-ZEBOV vaccine through three recent Ebola virus epidemics-West Africa, DRC Equateur and DRC Kivu: 4 years of excluding pregnant and lactating women and their infants from immunization"},{"title3":"CEPI to Fund Three Programmes to Develop Vaccines against the Novel Coronavirus, nCoV-2019. 23 January 2020"},{"title3":"A Dozen Vaccine Programs Underway as WHO Declares Coronavirus Public Health Emergency. Biocentury. 30 January 2020"},{"title3":"WHO Target Product Profiles for MERS-CoV Vaccines"},{"title3":"When is it acceptable to vaccinate pregnant women? Risk, ethics, and politics of governance in epidemic crises"},{"title3":"Chinese Baby Tests Positive for Coronavirus 30 Hours after Birth"},{"title3":"A Pregnant Mother Infected with the Coronavirus Gave Birth, and Her Baby Tested Positive 30 Hours Later"},{"title3":"Coronavirus: Doctors Fear Pregnant Women Can Pass on Illness after Newborn Baby Is Diagnosed"},{"title3":"Expert Reaction to Newborn Baby Testing Positive for Coronavirus in Wuhan"},{"title3":"Zika virus infection in pregnancy, microcephaly and maternal and fetal health:What we think, what we know, and what we think we know"}]},{"title2":"Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts' consensus statement","References":[{"title3":"National Health Commission of People's Republic of China. https://www.nhc.gov.cn/xcs/yqfkdt/202001/a53e6df293cc4ff0b5a16ddf7b6b2b31.shtml. Access 20 Jan 2020."},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"National Health Commission of People's Republic of China. Diagnosis and treatment of pneumonia caused by novel coronavirus (trial version 4). https://www.nhc.gov.cn/xcs/zhengcwj/202001/4294563ed35b43209b31739bd0785e67/files/7a9309111267475a99d4306962c8bf78.pdf. Access 28 Jan 2020."},{"title3":"Suggestions on the diagnosis and treatment of novel coronavirus infection in children in Hubei province (trial version 1)"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person to-person transmission: a study of a family cluster"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical analysis of pediatric SARS cases in Beijing"},{"title3":"Concern for severe acute respiratory syndrom"},{"title3":"Clinical characteristics and prognosis of 33 children with severe acute respiratory syndrome in Guangzhou area"},{"title3":"Middle East respiratory syndrome coronavirus in children"},{"title3":"National Health Commission of People's Republic of China. Code for the diagnosis and treatment of community-acquired pneumonia in children (2019 edition). https://www.nhc.gov.cn/yzygj/s7653/201902/bfa758ad6add48a599bc74b588a6e89a.shtml. Access 11 Feb 2019."},{"title3":"Guidelines for management of community acquired pneumonia in children"},{"title3":"British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011"},{"title3":"The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America"},{"title3":"Global virus outbreaks: interferons as 1st responders"},{"title3":"Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study"},{"title3":"Recombinant human interferon alpha 2b broad-spectrum anti-respiratory viruses pharmacodynamics study in vitro"},{"title3":"Type I interferon potentiates IgA immunity to respiratory syncytial virus infection during infancy"},{"title3":"Expert consensus on rational application of interferon alpha in pediatrics"},{"title3":"Guidelines for rational drug use in children with wheezing disorders"},{"title3":"Study on the safety of recombinant human interferon 2b injection (pseudomonas) and hydroxyethyl starch 40 as excipient in SD rats"},{"title3":"National Health Commission of People's Republic of China. Guidelines on the diagnosis and treatment of hand, foot and mouth disease (2018 edition). https://www.nhc.gov.cn/yzygj/s3594q/201805/5db274d8697a41ea84e88eedd8bf8f63.shtml. Access 28 Jun 2018."},{"title3":"A multicenter controlled clinical study on the efficacy and safety of recombinant human interferon alpha2b spray in the treatment of hand, foot and mouth disease in children"},{"title3":"Expert consensus on diagnosis and treatment of herpetic pharyngitis (2019 edition)"},{"title3":"A multicenter, randomized, controlled clinical study on the efficacy and safety of recombinant human interferon 2b spray (pseudomonas) in the treatment of acute upper respiratory tract infection in children"},{"title3":"Preventive and therapeutic effects of recombinant IFN -alpha2b nasal spray on SARS-CoV infection in Macaca mulata"},{"title3":"A field trial of recombinant human interferon alpha-2b for nasal spray to prevent SARS and other respiratory viral infections"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"AbbVie Deutschland GmbH &amp; Co.KG. Lopinar veletonavir tablet specification. https://www.jianke.com/product/79823.html. Access 7 July 2017."},{"title3":"The Experimental Study of the Anti-SARS-CoV Effect of Arbidole"},{"title3":"National Health Commission of People's Republic of China. Influenza diagnosis and treatment protocol (revised edition 2019). https://wenku.baidu.com/view/00f0d41d2079168884868762caaedd3383c4b57f.html. Access 30 Nov 2019."},{"title3":"World Health Organization. Home care for patients with suspected novel coronavirus (nCoV) infection presenting with mild symptoms and management of contacts. https://www.who.int/internal-publications-detail/home-care-for-patients-with-suspected-novel-coronavirus-(nCoV)-infection-presenting-with-mild-symptoms-and-management-of-contacts. Access 20 Jan 2020."},{"title3":"The US Centers for Disease Control and Prevention. Interim Guidance for Preventing 2019 Novel Coronavirus (2019-nCoV) from Spreading to Others in Homes and Communities. https://www.cdc.gov/coronavirus/2019-ncov/guidance-prevent-spread-chinese.html. Access 20 Jan 2020."},{"title3":"National Health Commission of People's Republic of China. Guidelines for transmission and prevention of novel coronaviruses. https://www.nhc.gov.cn/xcs/kpzs/202001/9e73060017d744aeafff8834fc0389f4.shtml. Access 27 Jan 2020."}]},{"title2":"Diagnosis and treatment of 2019 novel coronavirus infection in children: a pressing issue","References":[{"title3":"National Health Commission of People's Republic of China. https://www.nhc.gov.cn/xcs/yqfkdt/202001/a53e6df293cc4ff0b5a16ddf7b6b2b31.shtml. Accessed 30 Jan 2020."},{"title3":"Clinical analysis of pediatric SARS cases in Beijing"},{"title3":"Concern for severe acute respiratory syndrome"},{"title3":"Middle East respiratory syndrome coronavirus in children"},{"title3":"Inhibition of respiratory virus infection by locally applied interferon"},{"title3":"A multicenter randomized controlled clinical study of recombinant human interferon-typealpha1b in the treatment of viral pneumonia in children"},{"title3":"A multicenter study on the treatment of acute bronchiolitis by nebulized human recombinant human interferon-alpha 1b"},{"title3":"Effect of nebulized inhalation of recombinant human interferon alpha-1b on early treatment of severe hand, foot and mouth disease"},{"title3":"Rational use of interferon alpha in pediatrical clinical practice: experts' consensus statement"},{"title3":"A multicenter, randomized, controlled clinical study on the efficacy and safety of recombinant human interferon 2b spray (pseudomonas) in the treatment of acute upper respiratory tract infection in children"},{"title3":"Experimental study on the prevention and treatment of SARS-CoV infection in rhesus monkeys with recombinant human interferon 2b nasal spray"},{"title3":"Study on the pharmacodynamics of recombinant human interferon alpha 2b against respiratory viruses"},{"title3":"Experimental study of recombinant human interferon 2b aerosol in the prevention of respiratory virus infections such as SARS in human populations"},{"title3":"National Health Commission of People's Republic of China. Diagnosis and treatment of pneumonia caused by novel coronavirus (trial version 4). 2020. https://www.nhc.gov.cn/xcs/zhengcwj/202001/4294563ed35b43209b31739bd0785e67/files/7a9309111267475a99d4306962c8bf78.pdf. Accessed 28 Jan 2020."}]},{"title2":"Early epidemiological analysis of the coronavirus disease outbreak based on crowdsourced data: a population-level observational study","References":[{"title3":"Using &quot;outbreak science&quot; to strengthen the use of models during epidemics"},{"title3":"Severe respiratory disease concurrent with the circulation of H1N1 influenza"},{"title3":"Characterizing the epidemiology of the 2009 influenza A/H1N1 pandemic in Mexico"},{"title3":"Pandemic potential of a strain of influenza A (H1N1): early findings"},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome"},{"title3":"Characterizing Ebola transmission patterns based on internet news reports"},{"title3":"Pneumonia"},{"title3":"Comparative age distribution of influenza morbidity and mortality during seasonal influenza epidemics and the 2009 H1N1 pandemic"},{"title3":"Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020"},{"title3":"The incubation period of 2019-nCoV from publicly reported confirmed cases: estimation and application"},{"title3":"Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Hospitalizations for severe lower respiratory tract infections"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients"},{"title3":"Global mortality estimates for the 2009 Influenza Pandemic from the GLaMOR project: a modeling study"},{"title3":"Risk of 2019 novel coronavirus importations throughout China prior to the Wuhan quarantine"},{"title3":"Exposure patterns driving ebola transmission in west Africa: A retrospective observational study"}]},{"title2":"Detection of novel coronavirus by RT-PCR in stool specimen from asymptomatic child, China","References":[{"title3":"Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed."},{"title3":"Washington State 2019-nCoV Case Investigation Team. First case of 2019 novel coronavirus in the United States."},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China: implication for infection prevention and control measures."},{"title3":"Novel coronavirus-important information for clinicians."},{"title3":"Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents."},{"title3":"Consistent detection of 2019 novel coronavirus in saliva."},{"title3":"Concentration and detection of SARS coronavirus in sewage from Xiao Tang Shan Hospital and the 309th Hospital."}]},{"title2":"COVID-19, Australia: epidemiology report 6 (Reporting week ending 19: 00 AEDT 7 March 2020)","References":[]},{"title2":"Mitigate the effects of home confinement on children during the COVID-19 outbreak","References":[{"title3":"Ministry of Education: national elementary and middle school network cloud platform opens for free use today"},{"title3":"Notice of arrangement for &quot;suspension of school does not stop learning&quot; during the postponement for the opening of primary and secondary schools"},{"title3":"Understanding differences between summer vs. school obesogenic behaviors of children: the structured days hypothesis"},{"title3":"The psychological impact of quarantine and how to reduce it: rapid review of the evidence"},{"title3":"Ten-year secular trends in sleep/wake patterns in Shanghai and Hong Kong school-aged children: a tale of two cities"},{"title3":"Posttraumatic stress disorder in parents and youth after health-related disasters"},{"title3":"Playing to live: outcome evaluation of a community-based psychosocial expressive arts program for children during the Liberian Ebola epidemic"},{"title3":"Effectiveness of a brief behavioural intervention to prevent weight gain over the Christmas holiday period: randomised controlled trial"},{"title3":"Online mental health services in China during the COVID-19 outbreak"},{"title3":"Guideline for psychological crisis intervention during 2019-nCoV"},{"title3":"Coronavirus disease (COVID-19) advice for the public"},{"title3":"Parenting as primary prevention"},{"title3":"WHO Director-General's opening remarks at the media briefing on COVID-19 - 28 February 2020"},{"title3":"A future for the world's children? A WHO-UNICEF-Lancet Commission"}]},{"title2":"Chinese expert consensus on the perinatal and neonatal management for the prevention and control of the 2019 novel coronavirus infection (First edition)","References":[]},{"title2":"A case report of neonatal COVID-19 infection in China","References":[]},{"title2":"Pharmaceutical care recommendations for antiviral treatments in children with coronavirus disease 2019","References":[{"title3":"National Health Commission of the People's Republic of China. Notice on printing and distributing the diagnosis and treatment plan of COVID-19 (trial version 6). https://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2.shtml. Accessed 19 Feb 2020."},{"title3":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques"},{"title3":"A multicenter clinical study on the treatment for children's acute bronchiolitis by nebulized recombinant human interferon alpha1b"},{"title3":"The effect of recombinant human interferon alpha1b combined with human normal immunoglobulin on serum cytokine and immunoglobulins levels in bronchiolitis children"},{"title3":"The contrast observation of the clinical efficacy and safety of interferon nebulization and ribavirin in the treatment of infantile herpes angina"},{"title3":"Evaluation of efficacy and safety of interferon alpha2b spray for children with herpetic angina"},{"title3":"Comparison of the efficacy of nebulized inhaled interferon and intramuscular injection of interferon in the treatment of hand, foot and mouth disease"},{"title3":"Efficacy and safety of interferon-alpha2b spray in the treatment of hand, foot, and mouth disease: a multicenter, randomized, double blind trial"},{"title3":"Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts' consensus statement"},{"title3":"Expert consensus on reasonable application of interferon in pediatrics"},{"title3":"Expert consensus on clinical application of recombinant human interferon alpha1b in pediatrics"},{"title3":"Interferon alpha-2b injection. https://drugs.dxy.cn/drug/153953/detail.htm#14. Accessed 11 Feb 2020."},{"title3":"Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study"},{"title3":"Antiviral treatment guidelines for Middle East respiratory syndrome"},{"title3":"DailyMed. Lopinavir-ritonavir solution. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4b1caefa-e6a2-42f3-9194-6dc1dd9e6d85. Accessed 12 Feb 2020."},{"title3":"Lopinavir/ritonavir oral solution. https://drugs.dxy.cn/drug/58394/detail.htm#4. Accessed 24 Feb 2020."},{"title3":"Diagnosis and treatment recommendation for pediatric coronavirus disease-19 (the second edition)"},{"title3":"DailyMed. Kaletra-lopinavir and ritonavir tablet, film coated. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3fa34341-1dce-4bad-b97e-f466e96a0bbe. Accessed 1 Feb 2020."},{"title3":"UpToDate. Lopinavir and ritonavir. https://www.uptodate.com/contents/lopinavir-and-ritonavir-drug-information?search=lopinavir&amp;source=search_result&amp;selectedTitle=1~61&amp;usage_type=default&amp;display_rank=1. Accessed 6 Feb 2020."},{"title3":"DailyMed. Rebetol-ribavirin capsule/liquid. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=04d2b6f4-bd9b-4871-9527-92c81aa2d4d0. Accessed 11 Feb 2020."},{"title3":"Hemolytic anemia-induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage"},{"title3":"Ribavirin-induced adverse drug reactions (ADRs): literature review of 182 cases"},{"title3":"Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies"},{"title3":"National Health Commission of the People's Republic of China. Notice on printing and distributing the adjustment of dosage regimen of chloroquine diphosphate in COVID-19. https://www.nhc.gov.cn/yzygj/s7653p/202002/0293d017621941f6b2a4890035243730.shtml. Accessed 28 Feb 2020."},{"title3":"Treatment of severe chloroquine poisoning"},{"title3":"Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia"},{"title3":"Arbidol (umifenovir): a broad-spectrum antiviral drug that inhibits medically important arthropod-borne flaviviruses"},{"title3":"Drug treatment options for the 2019-new coronavirus (2019-nCoV)"},{"title3":"Research progress of non-nucleoside antiviral drug Arbidol"}]},{"title2":"Novel coronavirus infection in hospitalized infants under 1 year of age in China","References":[]},{"title2":"Clinical and CT features in pediatric patients with COVID-19 infection: different points from adults","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Novel coronavirus (2019-nCoV) early-stage importation risk to Europe, January 2020"},{"title3":"General Office of the National Health Commission of China. Diagnosis and Treatment Protocol for 2019-nCoV. 5th ed. Beijing, China: National Health Commission of China; 2020."},{"title3":"Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city"},{"title3":"Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health:the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia"},{"title3":"Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis"},{"title3":"Chest CT findings in 2019 novel coronavirus (2019-nCoV) infections from Wuhan, China: key points for the radiologist"},{"title3":"Emerging coronavirus 2019-nCoV pneumonia"},{"title3":"Differentiation of bacterial and viral pneumonia in children"}]},{"title2":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series","References":[]},{"title2":"Clinical strategies for treating pediatric cancer during the outbreak of 2019 novel coronavirus infection","References":[]},{"title2":"Corona Virus Disease 2019, a growing threat to children?","References":[{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"National Health Commission of People's Republique of China: Daily briefing on novel coronavirus cases in China. http://en.nhc.gov.cn/2020-02/18/c_76645.htm."},{"title3":"Emergence of a novel coronavirus causing respiratory illness from Wuhan, China"},{"title3":"Chinese center for disease control and prevention. epidemiological characteristics of novel coronavirus pneumonia"},{"title3":"World Health Organization: Home care for patients with suspected novel coronavirus (nCoV) infection presenting with mild symptoms and management of contacts. https://www.who.int/internal-publications-detail/home-care-for-patients-with-suspected-novel-coronavirus-(nCoV)-infection-presenting-with-mild-symptoms-and-management-of-contacts.2020."},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts'consensus statement"},{"title3":"Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, china"}]},{"title2":"Potential interventions for novel coronavirus in China: a systematic review","References":[{"title3":"Bats and coronaviruses"},{"title3":"Coronavirus envelope protein: current knowledge"},{"title3":"Middle East respiratory syndrome"},{"title3":"New SARS-like virus in China triggers alarm"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Coronaviruses: genome structure, replication, and pathogenesis"},{"title3":"Recent advances in the detection of respiratory virus infection in humans"},{"title3":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan"},{"title3":"Selenium, selenoproteins and viral infection"},{"title3":"Importance of vitamin A deficiency in pathology and immunology of viral infections"},{"title3":"Vitamin A and immunity to viral, bacterial and protozoan infections"},{"title3":"Vitamin A supplements ameliorate the adverse effect of HIV-1, malaria, and diarrheal infections on child growth"},{"title3":"Effects of dietary vitamin A content on antibody responses of feedlot calves inoculated intramuscularly with an inactivated bovine coronavirus vaccine"},{"title3":"Epithelia-damaging virus infections affect vitamin A status in chickens"},{"title3":"Retinoids inhibit measles virus through a type I IFN-dependent bystander effect"},{"title3":"Riboflavin (vitamin B-2) and health"},{"title3":"Inactivation of Middle East respiratory syndrome coronavirus (MERS-CoV) in plasma products using a riboflavin-based and ultraviolet light-based photochemical treatment"},{"title3":"C/EBPepsilon mediates nicotinamide-enhanced clearance of Staphylococcus aureus in mice"},{"title3":"Nicotinamide exacerbates hypoxemia in ventilator-induced lung injury independent of neutrophil infiltration"},{"title3":"Vitamin C and SARS coronavirus"},{"title3":"The effect of ascorbic acid on infection chick-embryo ciliated tracheal organ cultures by coronavirus"},{"title3":"Nutrients and their role in host resistance to infection"},{"title3":"Vitamin C intake and susceptibility to pneumonia"},{"title3":"Vitamin D insufficiency among free-living healthy young adults"},{"title3":"Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease"},{"title3":"Acute phase response elicited by experimental bovine diarrhea virus (BVDV) infection is associated with decreased vitamin D and E status of vitamin-replete preruminant calves"},{"title3":"Vitamin E metabolic effects and genetic variants: a challenge for precision nutrition in obesity and associated disturbances"},{"title3":"Vitamin E deficiency intensifies the myocardial injury of coxsackievirus B3 infection of mice"},{"title3":"Increased virulence of coxsackievirus B3 in mice due to vitamin E or selenium deficiency"},{"title3":"Macrophage-derived extracellular vesicles induce long-lasting immunity against hepatitis C virus which is blunted by polyunsaturated fatty acids"},{"title3":"Plasma fatty acid levels in patients with acquired immune deficiency syndrome and in controls"},{"title3":"The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza"},{"title3":"Anti-HCV activities of selective polyunsaturated fatty acids"},{"title3":"Selenium and human health"},{"title3":"Micronutrients and host resistance to viral infection"},{"title3":"Review: micronutrient selenium deficiency influences evolution of some viral infectious diseases"},{"title3":"Selenium deficiency increases the pathology of an influenza virus infection"},{"title3":"Rapid genomic evolution of a non-virulent coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates"},{"title3":"Combined adjuvant effect of ginseng stem-leaf saponins and selenium on immune responses to a live bivalent vaccine of Newcastle disease virus and infectious bronchitis virus in chickens"},{"title3":"Zinc and immunity: an essential interrelation"},{"title3":"Zinc deficiency"},{"title3":"Zinc supplementation for the treatment of measles in children"},{"title3":"Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture"},{"title3":"Crossing the iron gate: why and how transferrin receptors mediate viral entry"},{"title3":"Childhood iron deficiency anemia leads to recurrent respiratory tract infections and gastroenteritis"},{"title3":"Chicken interferon type I inhibits infectious bronchitis virus replication and associated respiratory illness"},{"title3":"Prevention of experimental coronavirus colds with intranasal alpha-2b interferon"},{"title3":"Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines"},{"title3":"In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds"},{"title3":"Interferon priming enables cells to partially overturn the SARS coronavirus-induced block in innate immune activation"},{"title3":"Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs"},{"title3":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial"},{"title3":"Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques"},{"title3":"Proposal for vaccination against SARS coronavirus using avian infectious bronchitis virus strain H from The Netherlands"},{"title3":"Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study"},{"title3":"Current treatment options and the role of peptides as potential therapeutic components for Middle East Respiratory Syndrome (MERS): a review"},{"title3":"Uses of intravenous gammaglobulin in immune hematologic disease"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Strokes, thromboembolic events, and IVIg: rare incidents blemish an excellent safety record"},{"title3":"Thymosin alpha 1 and HIV-1: recent advances and future perspectives"},{"title3":"A reappraisal of thymosin alpha1 in cancer therapy"},{"title3":"Serum thymosin alpha 1 levels in normal and pathological conditions"},{"title3":"Thymosin alpha 1 antagonizes dexamethasone and CD3-induced apoptosis of CD4+ CD8+ thymocytes through the activation of cAMP and protein kinase C dependent second messenger pathways"},{"title3":"Clinical investigation of outbreak of nosocomial severe acute respiratory syndrome"},{"title3":"Anti-SARS coronavirus agents: a patent review (2008-present)"},{"title3":"Modulation of immune response in aged humans through different administration modes of thymopentin"},{"title3":"Phase variation in the modulation of the human immune response"},{"title3":"Thymopentin as adjuvant in non-responders or hyporesponders to hepatitis B vaccination"},{"title3":"The general immunopharmacology of levamisole"},{"title3":"Lymphocyte subsets in measles. Depressed helper/inducer subpopulation reversed by in vitro treatment with levamisole and ascorbic acid"},{"title3":"Systemic cyclosporine and corneal transplantation"},{"title3":"Nucleocapsid protein of SARS coronavirus tightly binds to human cyclophilin A"},{"title3":"Factor in virus replication and potential target for anti-viral therapy"},{"title3":"The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors"},{"title3":"Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus"},{"title3":"Diarylheptanoids from Alnus japonica inhibit papain-like protease of severe acute respiratory syndrome coronavirus"},{"title3":"Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro"},{"title3":"Flavonoids: an overview"},{"title3":"Flavonoids from pterogyne nitens inhibit hepatitis C virus entry"},{"title3":"Inhibition of SARS-CoV 3CL protease by flavonoids"},{"title3":"Characteristics of flavonoids as potent MERS-CoV 3C-like protease inhibitors"},{"title3":"Biflavonoids from Torreya nucifera displaying SARS-CoV 3CL(pro) inhibition"},{"title3":"Angiotensin-converting enzyme-2: a molecular and cellular perspective"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"The secret life of ACE2 as a receptor for the SARS virus"},{"title3":"Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry"},{"title3":"Severe acute respiratory syndrome coronavirus entry into host cells: Opportunities for therapeutic intervention"},{"title3":"Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association"},{"title3":"Effects of chloroquine on viral infections: an old drug against today's diseases?"},{"title3":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread"},{"title3":"Membrane-related effects underlying the biological activity of the anthraquinones emodin and barbaloin"},{"title3":"Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction"},{"title3":"Old drugs as lead compounds for a new disease? Binding analysis of SARS coronavirus main proteinase with HIV, psychotic and parasite drugs"},{"title3":"The transition metal chelator nicotianamine is synthesized by filamentous fungi"},{"title3":"Nicotianamine is a novel angiotensin-converting enzyme 2 inhibitor in soybean"},{"title3":"Managing SARS amidst uncertainty"},{"title3":"Critics slam treatment for SARS as ineffective and perhaps dangerous"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"SARS: pharmacotherapy"},{"title3":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Combination therapy with lopinavir/ritonavir, ribavirin and interferon-alpha for Middle East respiratory syndrome"},{"title3":"Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Nelfinavir. A review of its therapeutic efficacy in HIV infection"},{"title3":"HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus"},{"title3":"Arbidol as a broad-spectrum antiviral: an update"},{"title3":"Arbidol: a broad-spectrum antiviral compound that blocks viral fusion"},{"title3":"The synthetic antiviral drug arbidol inhibits globally prevalent pathogenic viruses"},{"title3":"[Antiviral activity of arbidol and its derivatives against the pathogen of severe acute respiratory syndrome in the cell cultures]"},{"title3":"Nitric oxide"},{"title3":"Nitric oxide and airway disease"},{"title3":"Efficacy of inhaled nitric oxide in patients with severe ARDS"},{"title3":"An overview on severe acute respiratory syndrome (SARS)"},{"title3":"Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus"},{"title3":"Efficacy of thioctic acid in the therapy of peripheral diabetic neuropathy"},{"title3":"Biochemical and clinical relevance of alpha lipoic acid: antioxidant and anti-inflammatory activity, molecular pathways and therapeutic potential"},{"title3":"Effects of dietary vitamin C, vitamin E, and alpha-lipoic acid supplementation on the antioxidant defense system and immune-related gene expression in broilers exposed to oxidative stress by dexamethasone"},{"title3":"Glucose-6-phosphate dehydrogenase deficiency enhances human coronavirus 229E infection"},{"title3":"Alpha-lipoic acid is an effective inhibitor of human immuno-deficiency virus (HIV-1) replication"},{"title3":"Sexual dimorphism in innate immune responses to infectious organisms"},{"title3":"Do men have a higher case fatality rate of severe acute respiratory syndrome than women do?"},{"title3":"SARS in Singapore--predictors of disease severity"},{"title3":"The pattern of Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive epidemiological analysis of data from the Saudi Ministry of Health"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Endocrine cells of the adenohypophysis in severe acute respiratory syndrome (SARS)"},{"title3":"Estrogenic compounds reduce influenza A virus replication in primary human nasal epithelial cells derived from female, but not male, donors"},{"title3":"Effective inhibition of MERS-CoV infection by resveratrol"},{"title3":"Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses"},{"title3":"Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus"},{"title3":"Protection from SARS coronavirus conferred by live measles vaccine expressing the spike glycoprotein"},{"title3":"Live-attenuated bivalent measles virus-derived vaccines targeting Middle East respiratory syndrome coronavirus induce robust and multifunctional T cell responses against both viruses in an appropriate mouse model"},{"title3":"Measles-derived vaccines to prevent emerging viral diseases"},{"title3":"Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants"},{"title3":"Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets"},{"title3":"Convalescent plasma: new evidence for an old therapeutic tool?"},{"title3":"Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol"},{"title3":"Use of convalescent plasma therapy in SARS patients in Hong Kong"},{"title3":"Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients"}]},{"title2":"Anesthetic management of patients with suspected or confirmed 2019 novel coronavirus infection during emergency procedures","References":[{"title3":"Management of acute aortic dissection and thoracic aortic rupture"},{"title3":"Novel coronavirus disease (Covid-19): The first two patients in the UK with person to person transmission"},{"title3":"Detection of SARS-CoV-2 in different types of clinical specimens"},{"title3":"Dissecting aortic aneurysm and disseminated intravascular coagulation"},{"title3":"Tranexamic acid controlled chronic disseminated intravascular coagulation associated with aortic dissection and patent false lumen for three years"},{"title3":"The efficacy and safety of prophylactic corticosteroids for the prevention of adverse outcomes in patients undergoing heart surgery using cardiopulmonary bypass: a systematic review and meta-analysis of randomized controlled trials"},{"title3":"Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia"},{"title3":"ISTH interim guidance on recognition and management of coagulopathy in COVID-19"},{"title3":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia"},{"title3":"COVID19 coagulopathy in Caucasian patients"},{"title3":"The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease"},{"title3":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy"},{"title3":"Pulmonary and cardiac pathology in Covid-19: the first autopsy series from New Orleans [e-pub ahead of print]"},{"title3":"Clinical pathology of critical patient with novel coronavirus pneumonia (COVID-19)"},{"title3":"Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia"}]},{"title2":"Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia","References":[]},{"title2":"TheEpidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) : China, 2020. Chinese Journal of Epidemiology (by The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team)","References":[]},{"title2":"Coronavirus disease 2019 (COVID-19) in Italy","References":[{"title3":"The first report on coronavirus disease 2019 (COVID-19) vaccine refusal by patients with solid cancer in Italy: Early data from a single-institute survey"},{"title3":"Coronavirus Disease-2019 in cancer patients. A report of the first 25 cancer patients in a Western country (Italy)"},{"title3":"Cancer patients with COVID-19: a retrospective study of 51 patients in the district of Piacenza, Northern Italy"},{"title3":"Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates"},{"title3":"Adherence to COVID-19 vaccines in cancer patients: promote it and make it happen!"}]},{"title2":"Severe outcomes among patients with coronavirus disease 2019 (COVID-19) : United States, February 12-March 16, 2020","References":[{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China"}]},{"title2":"SARS-CoV-2 infection in children","References":[]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19)","References":[]},{"title2":"Posttraumatic stress disorder in parents and youth after health-related disasters","References":[]},{"title2":"Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2)","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia"},{"title3":"Structure, Function, and Evolution of Coronavirus Spike Proteins"},{"title3":"The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex"},{"title3":"Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion"},{"title3":"Cryo-electron microscopy structures of the SARS-CoV spike glycoprotein reveal a prerequisite conformational state for receptor binding"},{"title3":"Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen"},{"title3":"Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion"},{"title3":"Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains"},{"title3":"Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis"},{"title3":"cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination"},{"title3":"The 3.1-Angstrom Cryo-electron Microscopy Structure of the Porcine Epidemic Diarrhea Virus Spike Protein in the Prefusion Conformation"},{"title3":"Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy"},{"title3":"Pre-fusion structure of a human coronavirus spike protein"},{"title3":"Cathepsin L functionally cleaves the severe acute respiratory syndrome coronavirus class I fusion protein upstream of rather than adjacent to the fusion peptide"},{"title3":"Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites"},{"title3":"Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation"},{"title3":"The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells"},{"title3":"Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2"},{"title3":"Structural basis of neutralization by a human anti-severe acute respiratory syndrome spike protein antibody, 80R"},{"title3":"Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody"},{"title3":"Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody"},{"title3":"Leginon: an automated system for acquisition of images from vitreous ice specimens"},{"title3":"Real-time cryo-electron microscopy data preprocessing with Warp"},{"title3":"Automatic local resolution-based sharpening of cryo-EM maps"},{"title3":"PHENIX: building new software for automated crystallographic structure determination"},{"title3":"ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps"},{"title3":"Coot: model-building tools for molecular graphics"},{"title3":"Collaboration gets the most out of software"},{"title3":"cisTEM, user-friendly software for single-particle image processing"}]},{"title2":"Evolution of the immune system in humans from infancy to old age","References":[{"title3":"Immune response in silico (IRIS): immune-specific genes identified from a compendium of microarray expression data"},{"title3":"The 1918 influenza pandemic: insights for the 21st century"},{"title3":"Neutrophil and endothelial adhesive function during human fetal ontogeny"},{"title3":"Phagocytic ability of neutrophils and monocytes in neonates"},{"title3":"Monocyte toll-like receptor 4 expression and LPS-induced cytokine production increase during gestational aging"},{"title3":"Role of MyD88 in diminished tumor necrosis factor alpha production by newborn mononuclear cells in response to lipopolysaccharide"},{"title3":"Immaturity of infection control in preterm and term newborns is associated with impaired toll-like receptor signaling"},{"title3":"Human newborn polymorphonuclear neutrophils exhibit decreased levels of MyD88 and attenuated p38 phosphorylation in response to lipopolysaccharide"},{"title3":"Lipopolysaccharide-induced tumor necrosis factor-alpha and IL-10 production by lung macrophages from preterm and term neonates"},{"title3":"Phenotype and function of neonatal DC"},{"title3":"Impaired responses to toll-like receptor 4 and toll-like receptor 3 ligands in human cord blood"},{"title3":"Ontogeny of myeloid cells"},{"title3":"Preterm neonates display altered plasmacytoid dendritic cell function and morphology"},{"title3":"Neonatal natural killer cell function: relevance to antiviral immune defense"},{"title3":"Differentiation and functional regulation of human fetal NK cells"},{"title3":"Off to a slow start: under-development of the complement system in term newborns is more substantial following premature birth"},{"title3":"Dynamics of thymus-colonizing cells during human development"},{"title3":"The long road to the thymus: the generation, mobilization, and circulation of T-cell progenitors in mouse and man"},{"title3":"Fetal and adult hematopoietic stem cells give rise to distinct T cell lineages in humans"},{"title3":"CD25+CD4+ T cells in human cord blood: an immunoregulatory subset with naive phenotype and specific expression of forkhead box p3 (Foxp3) gene"},{"title3":"The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donors"},{"title3":"Human cord blood CD4+CD25hi regulatory T cells suppress prenatally acquired T cell responses to Plasmodium falciparum antigens"},{"title3":"The role of genetic and environmental factors in the development of T-cell mediated allergic disease in early life"},{"title3":"A defect in nucleosome remodeling prevents IL-12(p35) gene transcription in neonatal dendritic cells"},{"title3":"CD4+ T cells from human neonates and infants are poised spontaneously to run a nonclassical IL-4 program"},{"title3":"Acquisition of innate-like microbial reactivity in mucosal tissues during human fetal MAIT-cell development"},{"title3":"gammadelta T-cell conference 2012: close encounters for the fifth time"},{"title3":"Interleukin-8 (CXCL8) production is a signatory T cell effector function of human newborn infants"},{"title3":"Neonates harbour highly active gammadelta T cells with selective impairments in preterm infants"},{"title3":"Ordering human CD34+CD10-CD19+ pre/pro-B-cell and CD19- common lymphoid progenitor stages in two pro-B-cell development pathways"},{"title3":"A small CD11b+ human B1 cell subpopulation stimulates T cells and is expanded in lupus"},{"title3":"Developmental and maturational changes in human blood lymphocyte subpopulations"},{"title3":"Decreased expression of tumor necrosis factor family receptors involved in humoral immune responses in preterm neonates"},{"title3":"Pneumococcal polysaccharides complexed with C3d bind to human B lymphocytes via complement receptor type 2"},{"title3":"Antigen-dependent immunotherapy of non-obese diabetic mice with immature dendritic cells"},{"title3":"Complement receptors regulate differentiation of bone marrow plasma cell precursors expressing transcription factors Blimp-1 and XBP-1"},{"title3":"Somatic mutation of immunoglobulin VH6 genes in human infants"},{"title3":"Reduced ability of neonatal and early-life bone marrow stromal cells to support plasmablast survival"},{"title3":"Longevity of T-cell memory following acute viral infection"},{"title3":"On immunological memory"},{"title3":"Development of intestinal microbiota in infants and its impact on health"},{"title3":"The gut microbiota shapes intestinal immune responses during health and disease"},{"title3":"Do most lymphocytes in humans really reside in the gut?"},{"title3":"Focused specificity of intestinal TH17 cells towards commensal bacterial antigens"},{"title3":"Induction of intestinal Th17 cells by segmented filamentous bacteria"},{"title3":"Proteome-wide analysis of HIV-specific naive and memory CD4+ T cells in unexposed blood donors"},{"title3":"Coordination of tolerogenic immune responses by the commensal microbiota"},{"title3":"Virus-specific CD4+ memory-phenotype T cells are abundant in unexposed adults"},{"title3":"Lymphocyte subsets in healthy children from birth through 18 years of age: the pediatric AIDS clinical trials group P1009 study"},{"title3":"Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses"},{"title3":"Effects of dendritic cells from cord blood CD34+ cells on human hepatocarcinoma cell line BEL-7402 in vitro and in SCID mice"},{"title3":"Induction of colonic regulatory T cells by indigenous Clostridium species"},{"title3":"The induction of Treg cells by gut-indigenous Clostridium"},{"title3":"Interactions between commensal intestinal bacteria and the immune system"},{"title3":"IgA responses in the intestinal mucosa against pathogenic and non-pathogenic microorganisms"},{"title3":"HIV-1 envelope gp41 antibodies can originate from terminal ileum B cells that share cross-reactivity with commensal bacteria"},{"title3":"Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study"},{"title3":"An engineered human IgG1 antibody with longer serum half-life"},{"title3":"The maintenance and regulation of the humoral immune response: persisting antigen and the role of follicular antigen-binding dendritic cells as accessory cells"},{"title3":"Redefining chronic viral infection"},{"title3":"Germinal centres: role in B-cell physiology and malignancy"},{"title3":"Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo"},{"title3":"Differential usage of T cell receptor V gene segments in CD4+ and CD8+ subsets of T lymphocytes in monozygotic twins"},{"title3":"The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens"},{"title3":"The immune system in pregnancy: a unique complexity"},{"title3":"Immunology of the maternal-fetal interface"},{"title3":"Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates"},{"title3":"A class I antigen, HLA-G, expressed in human trophoblasts"},{"title3":"Uterine NK cells: active regulators at the maternal-fetal interface"},{"title3":"Regulatory T cells mediate maternal tolerance to the fetus"},{"title3":"Amino acid catabolism: a pivotal regulator of innate and adaptive immunity"},{"title3":"The remission of rheumatoid arthritis during pregnancy"},{"title3":"Influenza in pregnancy"},{"title3":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer"},{"title3":"Immunology beats cancer: a blueprint for successful translation"},{"title3":"T-cell receptor affinity and avidity defines antitumor response and autoimmunity in T-cell immunotherapy"},{"title3":"Malignancy in renal transplantation"},{"title3":"The aging of the immune system"},{"title3":"Lineage structure of the human antibody repertoire in response to influenza vaccination"},{"title3":"Epidemiology and unique aspects of aging and infectious diseases"},{"title3":"Molecular inflammation: underpinnings of aging and age-related diseases"},{"title3":"Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains"},{"title3":"Ageing and gut microbes: perspectives for health maintenance and longevity"},{"title3":"Diet, gut microbiota and immune responses"},{"title3":"Aging, autoimmunity and arthritis: T-cell senescence and contraction of T-cell repertoire diversity:catalysts of autoimmunity and chronic inflammation"},{"title3":"Premature CD4+ T cell aging and its contribution to lymphopenia-induced proliferation of memory cells in autoimmune-prone non-obese diabetic mice"},{"title3":"Immunity, ageing and cancer"},{"title3":"Derivation and maintenance of virtual memory CD8 T cells"},{"title3":"Inflamm-ageing and lifelong antigenic load as major determinants of ageing rate and longevity"},{"title3":"CD137 ligand reverse signaling skews hematopoiesis towards myelopoiesis during aging"},{"title3":"Immunoaging induced by hematopoietic stem cell aging"},{"title3":"Age-dependent alterations of Fc gamma receptor-mediated effector functions of human polymorphonuclear leucocytes"},{"title3":"Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders"},{"title3":"Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans"},{"title3":"Increased circulating Interleukin-18 levels in centenarians with no signs of vascular disease: another paradox of longevity?"},{"title3":"The senescence-associated secretory phenotype: the dark side of tumor suppression"},{"title3":"The illusion of cell immortality"},{"title3":"Telomeres and telomerase: their mechanisms of action and the effects of altering their functions"},{"title3":"Telomerase in T lymphocytes: use it and lose it?"},{"title3":"Age-related oxidative stress compromises endosomal proteostasis"},{"title3":"Autophagy and the immune function in aging"},{"title3":"A novel method for autophagy detection in primary cells: impaired levels of macroautophagy in immunosenescent T cells"},{"title3":"The autophagy protein Atg7 is essential for hematopoietic stem cell maintenance"},{"title3":"Autophagy is a critical regulator of memory CD8+ T cell formation"},{"title3":"The future of ageing"}]},{"title2":"Novel corona virus disease (COVID-19) in pregnancy: What clinical recommendations to follow?","References":[]}]},{"title1":"Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)","References":[{"title2":"National Health Commission of the People's Republic of China, Update on the novel coronavirus pneumonia outbreak; www.nhc.gov.cn/xcs/yqtb/list_gzbd.shtml.","References":[]},{"title2":"World Health Organization, Coronavirus disease (COVID-2019) situation reports; www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/.","References":[]},{"title2":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster","References":[{"title3":"CHP closely monitors cluster of pneumonia cases on Mainland"},{"title3":"CHP provides further information on cluster of pneumonia cases in Wuhan"},{"title3":"Wuhan wet market closes amid pneumonia outbreak"},{"title3":"Viral load in patients infected with pandemic H1N1 2009 influenza A virus"},{"title3":"Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: a diagnostic validity study"},{"title3":"Evaluation of NxTAG Respiratory pathogen panel and comparison with xTAG respiratory viral panel fast v2 and film array respiratory panel for detecting respiratory pathogens in nasopharyngeal aspirates and swine/avian-origin influenza A subtypes in culture isolates"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Zika virus infection in dexamethasone-immunosuppressed mice demonstrating disseminated infection with multi-organ involvement including orchitis effectively treated by recombinant type I interferons"},{"title3":"High prevalence of four novel astrovirus genotype species identified from rodents in China"},{"title3":"Metagenomic analysis of viromes of dromedary camel fecal samples reveals large number and high diversity of circoviruses and picobirnaviruses"},{"title3":"Identification of a novel bat papillomavirus by metagenomics"},{"title3":"Metagenomic nanopore sequencing of influenza virus direct from clinical respiratory samples"},{"title3":"Severe acute respiratory syndrome (SARS) coronavirus ORF8 protein is acquired from SARS-related coronavirus from greater horseshoe bats through recombination"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection"},{"title3":"A patient with asymptomatic severe acute respiratory syndrome (SARS) and antigenemia from the 2003-2004 community outbreak of SARS in Guangzhou, China"},{"title3":"Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome"},{"title3":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease"},{"title3":"Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus"},{"title3":"Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"Viral loads in clinical specimens and SARS manifestations"},{"title3":"Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome"},{"title3":"Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia"},{"title3":"Discovery of seven novel mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus"},{"title3":"Discovery of a novel coronavirus, China Rattus coronavirus HKU24, from Norway rats supports the murine origin of Betacoronavirus 1 and has implications for the ancestor of Betacoronavirus lineage A"},{"title3":"Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43"}]},{"title2":"Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020","References":[{"title3":"Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses."},{"title3":"Bat Coronaviruses in China."},{"title3":"Epidemic and Emerging Coronaviruses (Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome)."},{"title3":"Molecular epidemiology of the novel coronavirus that causes severe acute respiratory syndrome."},{"title3":"World Health Organization Regional Office for the (WHO/Eastern Mediterranean). MERS Situation Update. Cairo: WHO/Eastern Mediterranean; Nov2019. [Accessed 11 Jan 2020]. Available from: http://applications.emro.who.int/docs/EMRPUB-CSR-241-2019-EN.pdf?ua=1&amp;ua=1 "},{"title3":"Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015."},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea, 2015: epidemiology, characteristics and public health implications."},{"title3":"MERS, SARS, and Ebola: The Role of Super-Spreaders in Infectious Disease."},{"title3":"The role of superspreading in Middle East respiratory syndrome coronavirus (MERS-CoV) transmission."},{"title3":"Unusual presentation of Middle East respiratory syndrome coronavirus leading to a large outbreak in Riyadh during 2017."},{"title3":"World Health Organization (WHO). WHO Statement Regarding Cluster of Pneumonia Cases in Wuhan, China. Beijing: WHO; 9 Jan 2020. [Accessed 11 Jan 2020]. https://www.who.int/china/news/detail/09-01-2020-who-statement-regarding-cluster-of-pneumonia-cases-in-wuhan-china "},{"title3":"Wuhan Municipal Health Commission. [Update on outbreak of pneumonia cases in Wuhan]. 31 Dec 2019. [Accessed 13 Jan 2020]. Chinese. Available from: http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989 "},{"title3":"Beijing News. [Southern China Seafood Market linked to unexplained pneumonia outbreak]. 2 Jan 2020. [Accessed 13 Jan 2020]. Chinese. Available from: http://epaper.bjnews.com.cn/html/2020-01/02/content_775695.htm "},{"title3":"Wuhan Municipal Health Commission. [Report on unexplained viral pneumonia]. 5 Jan 2020. [Accessed 21 Jan 2020]. Chinese. Available from: http://wjw.wuhan.gov.cn/front/web/showDetail/2020010509020 "},{"title3":"Wuhan Municipal Health Commission. [Report on unexplained viral pneumonia]. 11 Jan 2020. [Accessed 21 Jan 2020]. Chinese. Available from: http://wjw.wuhan.gov.cn/front/web/showDetail/2020011109035 "},{"title3":"Cheung J. Ill husband and wife add to Wuhan riddle. Hong Kong; The Standard; 16 Jan 2020. [Accessed 20 Jan 2020]. Available from: https://www.thestandard.com.hk/sections-news-print/215457/Ill-husband-and-wife--add-to-Wuhan-riddle "},{"title3":"Using routine surveillance data to estimate the epidemic potential of emerging zoonoses: application to the emergence of US swine origin influenza A H3N2v virus."},{"title3":"Wuhan Municipal Health Commission. [Questions and answers on pneumonia due to novel coronavirus infection]. 14 Jan 2020. [Accessed 20 Jan 2020]. Chinese. Available from: http://wjw.wuhan.gov.cn/front/web/showDetail/2020011509040 "},{"title3":"Transmission scenarios for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and how to tell them apart."},{"title3":"World Health Organization Regional Office for the Western Pacific (WHO/Pacific). World Health Organization Western Pacific Twitter Feed. Manila: WHO/Pacific; 8:35 PM 20 Jan 2020. Available from: https://twitter.com/WHOWPRO "},{"title3":"Human infection with avian influenza A H7N9 virus: an assessment of clinical severity."},{"title3":"Methods for estimating the case fatality ratio for a novel, emerging infectious disease."},{"title3":"Clinical prognostic rules for severe acute respiratory syndrome in low- and high-resource settings."},{"title3":"A comparative epidemiologic analysis of SARS in Hong Kong, Beijing and Taiwan."},{"title3":"Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission."},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients."},{"title3":"Non-parametric estimation of the case fatality ratio with competing risks data: an application to Severe Acute Respiratory Syndrome (SARS)."},{"title3":"Chinese National Health Commission (NHC). [Experts answer reporters' questions on pneumonia outbreak of new coronavirus infection]. Beijing: NHC; 20 Jan 2020. [Accessed 20 Jan 2020]. Chinese http://www.nhc.gov.cn/xcs/s7847/202001/8d735f0bb50b45af928d9944d16950c8.shtml "},{"title3":"Chinese National Health Commission (NHC). [Press conference in response to the outbreak of pneumonia caused by 2019-nCoV]. Beijing: NHC; 21 Jan 2020. [Accessed 21 Jan 2020]. Chinese. Available from: http://www.nhc.gov.cn/xcs/s7847/202001/8d735f0bb50b45af928d9944d16950c8.shtml "},{"title3":"World Health Organization (WHO). Novel Coronavirus - Thailand (ex-China). Geneva: WHO: 14 Jan 2020. Available from: https://www.who.int/csr/don/14-january-2020-novel-coronavirus-thailand/en/ "},{"title3":"World Health Organization (WHO). Novel Coronavirus - Japan (ex-China). Geneva: WHO; 16 Jan 2020. Available from: https://www.who.int/csr/don/16-january-2020-novel-coronavirus-japan-ex-china/en/ "},{"title3":"Centers for Disease Control and Prevention (CDC). First Travel-related Case of 2019 Novel Coronavirus Detected in United States. Atlanta: CDC; 21 Jan 2020. Available from: https://www.cdc.gov/media/releases/2020/p0121-novel-coronavirus-travel-case.html "},{"title3":"Taiwan Centers for Disease Control (CDC). Taiwan timely identifies first imported case of severe special infectious pneumonia from Wuhan, China through onboard quarantine; Central Epidemic Command Center (CECC) raises travel notice level for Wuhan, China to Level 3: Warning. Taipei City: CDC; 21 Jan 2020. Available from: https://www.cdc.gov.tw/En/Bulletin/Detail/pVg_jRVvtHhp94C6GShRkQ?typeid=158 "}]},{"title2":"A novel coronavirus emerging in China:Key questions for impact assessment","References":[]},{"title2":"Risk for transportation of 2019 novel coronavirus disease from Wuhan to other cities in China","References":[]},{"title2":"X. Qiao, &quot;2018 Chunyun ended, 74.8% surveyed travelers felt satisfied&quot; [in Chinese], People's Daily, 15 March 2018; http://society.people.com.cn/n1/2018/0315/c1008-29869526.html.","References":[]},{"title2":"Inference for nonlinear dynamical systems","References":[]},{"title2":"Inapparent infections and cholera dynamics","References":[]},{"title2":"Inference and control of the nosocomial transmission of methicillin-resistant Staphylococcus aureus","References":[{"title3":"An ensemble adjustment kalman filter for data assimilation"},{"title3":"A tutorial on particle filters for online nonlinear/non-gaussian bayesian tracking"},{"title3":"Mathematical models of infection transmission in healthcare settings: recent advances from the use of network structured data"},{"title3":"Approximate Bayesian computation in population genetics"},{"title3":"A clarification of transmission terms in host-microparasite models: numbers, densities and areas"},{"title3":"Controlling methicillin-resistant Staphylococcus aureus: Quantifying the effects of interventions and rapid diagnostic testing"},{"title3":"Role of social networks in shaping disease transmission during a community outbreak of 2009 H1N1 pandemic influenza"},{"title3":"Methods to infer transmission risk factors in complex outbreak data"},{"title3":"Unraveling the drivers of MERS-CoV transmission"},{"title3":"Antibiotic Resistance Threats in the United States"},{"title3":"Antibiotic/antimicrobial Resistance"},{"title3":"The changing epidemiology of Staphylococcus aureus?"},{"title3":"Efficient surveillance for healthcare-associated infections spreading between hospitals"},{"title3":"Power-Law distributions in empirical data"},{"title3":"Systematic review of isolation policies in the hospital management of methicillin-resistant Staphylococcus aureus: a review of the literature with epidemiological and economic modelling"},{"title3":"Methicillin-resistant Staphylococcus aureus in hospitals and the community: stealth dynamics and control catastrophes"},{"title3":"Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (MRSA): systematic review of the literature"},{"title3":"Modeling the Invasion of Community-Acquired Methicillin-ResistantStaphylococcus aureusinto Hospitals"},{"title3":"Nasal carriage of epidemic methicillin-resistant Staphylococcus aureus 15 (EMRSA-15) clone observed in three chicago-area long-term care facilities"},{"title3":"Patient referral patterns and the spread of hospital-acquired infections through national health care networks"},{"title3":"Measuring dynamic social contacts in a rehabilitation hospital: effect of wards, patient and staff characteristics"},{"title3":"Consideration of age at admission for selective screening to identify methicillin-resistant Staphylococcus aureus carriers to control dissemination in a medical ward"},{"title3":"Bayesian inference of hospital-acquired infectious diseases and control measures given imperfect surveillance data"},{"title3":"Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat"},{"title3":"Geographic distribution of Staphylococcus aureus causing invasive infections in Europe: a molecular-epidemiological analysis"},{"title3":"Mathematical modelling: a tool for hospital infection control"},{"title3":"Evolution of MRSA during hospital transmission and intercontinental spread"},{"title3":"Plug-and-play inference for disease dynamics: measles in large and small populations as a case study"},{"title3":"Nosocomial transmission of community-associated methicillin-resistant Staphylococcus aureus in danish hospitals"},{"title3":"Risk factors for colonization with methicillin-resistant Staphylococcus aureus (MRSA) in patients admitted to an urban hospital: emergence of community-associated MRSA nasal carriage"},{"title3":"Modelling the costs and effects of selective and universal hospital admission screening for methicillin-resistant Staphylococcus aureus"},{"title3":"Inference for nonlinear dynamical systems"},{"title3":"Iterated filtering"},{"title3":"National prevalence of methicillin-resistant Staphylococcus aureus in inpatients at United States health care facilities, 2010"},{"title3":"Contact networks and the spread of mrsa in stockholm hospitals"},{"title3":"Methicillin-resistant Staphylococcus aureus: the European landscape"},{"title3":"Modelling an outbreak of an emerging pathogen"},{"title3":"Evaluation of mechanistic and statistical methods in forecasting influenza-like illness"},{"title3":"Equation-Free, Coarse-Grained multiscale computation: enabling mocroscopic simulators to perform system-level analysis"},{"title3":"Inapparent infections and cholera dynamics"},{"title3":"Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005"},{"title3":"Invasive methicillin-resistant Staphylococcus aureus infections in the United States"},{"title3":"Hospital-community interactions foster coexistence between methicillin-resistant strains of Staphylococcus aureus"},{"title3":"Assessing the role of undetected colonization and isolation precautions in reducing methicillin-resistant Staphylococcus aureus transmission in intensive care units"},{"title3":"Epidemiology of MRSA in southern Sweden: strong relation to foreign country of origin, health care abroad and foreign travel"},{"title3":"Absence of patient-to-patient intrahospital transmission of staphylococcus aureus as determined by whole-genome sequencing"},{"title3":"Staphylococcus aureus infections"},{"title3":"Modeling the transmission of community-associated methicillin-resistant Staphylococcus aureus: a dynamic agent-based simulation"},{"title3":"Multistate point-prevalence survey of health care-associated infections"},{"title3":"Origins of power-law degree distribution in the heterogeneity of human activity in social networks"},{"title3":"Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection"},{"title3":"Spread of hospital-acquired infections: A comparison of healthcare networks"},{"title3":"Interindividual Contacts and Carriage of Methicillin-Resistant Staphylococcus aureus: A Nested Case-Control Study"},{"title3":"Detailed contact data and the dissemination of Staphylococcus aureus in hospitals"},{"title3":"Contribution of mathematical modeling to the fight against bacterial antibiotic resistance"},{"title3":"Spreading dynamics in complex networks"},{"title3":"Searching for superspreaders of information in real-world social media"},{"title3":"Counteracting structural errors in ensemble forecast of influenza outbreaks"},{"title3":"Efficient collective influence maximization in cascading processes with first-order transitions"},{"title3":"Forecasting the spatial transmission of influenza in the United States"},{"title3":"Theories for influencer identification in complex networks."},{"title3":"Modeling contact networks of patients and mrsa spread in swedish hospitals"},{"title3":"Forecasting seasonal outbreaks of influenza"},{"title3":"Vital signs: estimated effects of a coordinated approach for action to reduce antibiotic-resistant infections in health care facilities - United States"},{"title3":"Strategic interactions in multi-institutional epidemics of antibiotic resistance"},{"title3":"Obstacles to high-dimensional particle filtering"},{"title3":"Epidemiology of methicillin-resistant staphylococci in Europe"},{"title3":"Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in Sweden 2000-2003, increasing incidence and regional differences"},{"title3":"Imported methicillin-resistant Staphylococcus aureus, Sweden"},{"title3":"Orthogonal array-based latin hypercubes"},{"title3":"Peripatetic health-care workers as potential superspreaders"},{"title3":"Collective influence of multiple spreaders evaluated by tracing real information flow in large-scale social networks"},{"title3":"Extended models for nosocomial infection: parameter estimation and model selection"},{"title3":"Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002"},{"title3":"Evidence for community transmission of community-associated but not health-care-associated methicillin-resistant staphylococcus aureus strains linked to social and material deprivation: spatial analysis of cross-sectional data"},{"title3":"Modelling the transmission of healthcare associated infections: a systematic review"},{"title3":"Estimating potential infection transmission routes in hospital wards using wearable proximity sensors"},{"title3":"A data-driven mathematical model of CA-MRSA transmission among age groups: evaluating the effect of control interventions"},{"title3":"Antimicrobial resistance fact sheet"},{"title3":"Estimating the effectiveness of isolation and decolonization measures in reducing transmission of methicillin-resistant Staphylococcus aureus in hospital general wards"},{"title3":"Inference of seasonal and pandemic influenza transmission dynamics"},{"title3":"Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat"}]},{"title2":"Health Commission of Hubei Province, The 8th Press Conference on the Prevention and Control of COVID-19; wjw.hubei.gov.cn/fbjd/dtyw/202001/t20200130_2016544.shtml.","References":[]},{"title2":"Health Commission of Hubei Province, The 9th Press Conference on the Prevention and Control of COVID-19; wjw.hubei.gov.cn/fbjd/dtyw/202001/t20200131_2017018.shtml.","References":[]},{"title2":"Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: A modelling study","References":[{"title3":"Superspreading and the effect of individual variation on disease emergence"},{"title3":"Model parameters and outbreak control for SARS"},{"title3":"Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions"},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome"},{"title3":"Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study"},{"title3":"The role of superspreading in Middle East respiratory syndrome coronavirus (MERS-CoV) transmission"},{"title3":"Unraveling the drivers of MERS-CoV transmission"},{"title3":"MERS transmission and risk factors: a systematic review"},{"title3":"Clinical impact of human coronaviruses 229E and OC43 infection in diverse adult populations"},{"title3":"Epidemiology characteristics of human coronaviruses in patients with respiratory infection symptoms and phylogenetic analysis of HCoV-OC43 during 2010-2015 in Guangzhou"},{"title3":"Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients"},{"title3":"A comparative epidemiologic analysis of SARS in Hong Kong, Beijing and Taiwan"},{"title3":"Comparison of incubation period distribution of human infections with MERS-CoV in South Korea and Saudi Arabia"},{"title3":"Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event"},{"title3":"Incubation periods of acute respiratory viral infections: a systematic review"},{"title3":"Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015"},{"title3":"Seroprevalence of IgG antibodies to SARS-coronavirus in asymptomatic or subclinical population groups"},{"title3":"Comparative serological study for the prevalence of anti-MERS coronavirus antibodies in high-and low-risk groups in Qatar"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) neutralising antibodies in a high-risk human population, Morocco, November 2017 to January 2018"},{"title3":"Development and application of an enzyme immunoassay for coronavirus OC43 antibody in acute respiratory illness"},{"title3":"Examination of seroprevalence of coronavirus HKU1 infection with S protein-based ELISA and neutralization assay against viral spike pseudotyped virus"},{"title3":"Middle East respiratory syndrome: what we learned from the 2015 outbreak in the Republic of Korea"},{"title3":"An outbreak of human coronavirus OC43 infection and serological cross-reactivity with SARS coronavirus"},{"title3":"Human coronavirus alone or in co-infection with rhinovirus C is a risk factor for severe respiratory disease and admission to the pediatric intensive care unit: a one-year study in Southeast Brazil"},{"title3":"Case fatality of SARS in mainland China and associated risk factors"},{"title3":"Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk"},{"title3":"Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility"},{"title3":"The SARS epidemic in Hong Kong: what lessons have we learned?"},{"title3":"SARS in healthcare facilities, Toronto and Taiwan"},{"title3":"Wuhan is expected to send 15 million passengers during Spring Festival in 2020 (in Chinese)"},{"title3":"An outbreak of NCIP (2019-nCoV) infection in China:Wuhan, Hubei Province, 2019-2020"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Characterizing the dynamics underlying global spread of epidemics"},{"title3":"The effect of public health measures on the 1918 influenza pandemic in U.S. cities"},{"title3":"Frequently asked questions about SARS"},{"title3":"Real-time epidemic forecasting: challenges and opportunities"},{"title3":"Outbreak analytics: a developing data science for informing the response to emerging pathogens"},{"title3":"Improving the evidence base for decision making during a pandemic: the example of 2009 influenza A/H1N1"},{"title3":"MRC Centre for Global Infectious Disease Analysis: Wuhan coronavirus reports 1-3"},{"title3":"Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions"},{"title3":"Transmission dynamics of 2019 novel coronavirus (2019-nCoV)"},{"title3":"Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak"},{"title3":"Announcement of the State Administration of Market Supervision, Ministry of Agriculture and Rural Affairs, and the National Forestry and Grass Bureau on banning wildlife trading (in Chinese)"}]},{"title2":"Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020","References":[{"title3":"World Health Organization (WHO). Pneumonia of unknown cause - China. Geneva: WHO; 2020. Available from: https://www.who.int/csr/don/05-january-2020-pneumonia-of-unkown-cause-china/en/ "},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.."},{"title3":"Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, et al. Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. bioRxiv. 2020;10.1101/2020.01.22.914952. Available from: https://www.biorxiv.org/content/early/2020/01/23/2020.01.22.914952 "},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"World Health Organization (WHO). Novel Coronavirus (2019-nCoV) situation report 9. Geneva: WHO; 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200129-sitrep-9-ncov-v2.pdf?sfvrsn=e2c8915_2 "},{"title3":"Imai N, Dorigatti I, Cori A, Donnelly C, Riley S, Ferguson NM. Report 2: Estimating the potential total number of novel Coronavirus cases in Wuhan City, China. London: Imperial College; 2020. Available from: https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/news--wuhan-coronavirus/ "},{"title3":"Superspreading and the effect of individual variation on disease emergence."},{"title3":"Ebola superspreading."},{"title3":"The role of superspreading in Middle East respiratory syndrome coronavirus (MERS-CoV) transmission."},{"title3":"Rambaut A. Preliminary phylogenetic analysis of 11 nCoV2019 genomes, 2020-01-19. ARTIC Network; 2020. Available from: http://virological.org/t/preliminary-phylogenetic-analysis-of-11-ncov2019-genomes-2020-01-19/329 "},{"title3":"R Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2018. Available from: http://www.R-project.org/"},{"title3":"Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk."},{"title3":"Effectiveness of control measures during the SARS epidemic in Beijing: a comparison of the Rt curve and the epidemic curve."},{"title3":"Influenza transmission in households during the 1918 pandemic."},{"title3":"Middle EAST respiratory syndrome coronavirus superspreading event involving 81 persons, Korea 2015."},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus."}]},{"title2":"N. Imai, I. Dorigatti, A. Cori, C. Donnelly, S. Riley, N. M. Ferguson, Report 2: Estimating the potential total number of novel Coronavirus cases in Wuhan City, China (Imperial College London, 2020); http://hdl.handle.net/10044/1/77150.","References":[]},{"title2":"Baidu Migration; https://qianxi.baidu.com/.","References":[{"title3":"Resilience and regions: Building understanding of the metaphor"},{"title3":"Towards the resilient region?"},{"title3":"Managing for local resilience: Towards a strategic approach"},{"title3":"COVID-19, food insecurity, and migration"},{"title3":"COVID-19 sets off mass migration in India"},{"title3":"Sharpening our public health lens: Advancing im/migrant health equity during COVID-19 and beyond"},{"title3":"Migration and development: A theoretical perspective"},{"title3":"Dualism and cross-country growth regressions"},{"title3":"How important are dual economy effects for aggregate productivity?"},{"title3":"Labor mobility, industrialization and regional economic growth: An empirical study based on non-parametric additive model"},{"title3":"The political economy of domestic labor mobility: Specific factors, landowners, and education"},{"title3":"Migrant networks and foreign direct investment"},{"title3":"Migration, ethnic concentration and firm entry: Evidence from Italian regions"},{"title3":"Testing and explaining economic resilience with an application to I talian regions"},{"title3":"The role of industrial diversity in economic resilience: An empirical examination across 35 years"},{"title3":"Towards an evolutionary perspective on regional resilience"},{"title3":"Engines of innovation"},{"title3":"Capital flows and GDP in emerging economies and the role of global spillovers"},{"title3":"Migration and innovation: Does cultural diversity matter for regional R&amp;D activity?"},{"title3":"Knowledge Spillovers through Labour Mobility: An Employer-Employee Analysis"},{"title3":"Playing 3D chess, or how firms can thrive under complexity: The mediating role of innovation capabilities in the use of innovation input"},{"title3":"Determinants of regional resilience to economic crisis: A European perspective"},{"title3":"Attributes and characteristics of regional resilience: Defining and measuring the resilience of Turkish regions"},{"title3":"Human capital, economic growth, and regional inequality in China"},{"title3":"Evaluation on the Effect of Regional Innovation Under the Technological Talent Aggregation"},{"title3":"Capital accumulation and growth: A new look at the empirical evidence"},{"title3":"A Study on the Fixed Assets Investment of Yanbian Area in China"},{"title3":"The Analysis of the Composite Improved Models on the Relationship among Shenzhen's Economic Growth with Its Fixed-asset Investment and Export Volume"},{"title3":"China's urbanization in 1949-2015: Processes and driving forces"},{"title3":"Migration and social mobility: An approach from the assets accumulation strategies of latin american population in Spain"},{"title3":"Local entrepreneurial resilience and culture: The role of social values in fostering economic recovery"},{"title3":"The learning region: The impact of social capital and weak ties on innovation"},{"title3":"Regional economic resilience, hysteresis and recessionary shocks"},{"title3":"Lagrange multiplier test diagnostics for spatial dependence and spatial heterogeneity"},{"title3":"Resilience, adaptation and adaptability"},{"title3":"Resilient regions in an uncertain world: Wishful thinking or a practical reality?"},{"title3":"A validation of metrics for community resilience to natural hazards and disasters using the recovery from Hurricane Katrina as a case study"},{"title3":"Research on spatiotemporal differentiation and influence mechanism of urban resilience in China based on MGWR model"},{"title3":"Achieving resilience through smart cities? Evidence from China"},{"title3":"Spatial characteristics of urbanization in China from the perspective of inter-regional mobility"},{"title3":"Economic resilience: The case of Poland and certain European regions"},{"title3":"The inverted U-shaped model of labor flow across dialects"},{"title3":"Effects of topographic relief on the evolution of county population pattern in Northeast China"},{"title3":"Applied spatial econometrics: Raising the bar"},{"title3":"The relationship between house prices and demographic variables: An Australian case study"},{"title3":"Discussion on Sustainable Urbanization in Tibet"},{"title3":"Study on the Influence of Floating Population on Urban Economic Growth"},{"title3":"The lockdown, mobility, and spatial health disparities in COVID-19 pandemic: A case study of New York City"},{"title3":"Effects of human mobility restrictions on the spread of COVID-19 in Shenzhen, China: A modelling study using mobile phone data"},{"title3":"Is the Omicron variant of SARS-CoV-2 coming to an end?"},{"title3":"Bangladesh-India border issues: A critical review"}]},{"title2":"M. Kramer, D. Pigott, B. Xu, S. Hill, B. Gutierrez, O. Pybus, Epidemiological data from the nCoV-2019 Outbreak: Early Descriptions from Publicly Available Data; http://virological.org/t/epidemiological-data-from-the-ncov-2019-outbreak-early-descriptions-from-publicly-available-data/337.","References":[]},{"title2":"Factors that make an infectious disease outbreak controllable","References":[]},{"title2":"Forecasting the spatial transmission of influenza in the United States","References":[]},{"title2":"A. Rambaut, Phylodynamic Analysis | 129 genomes | 24 Feb 2020; http://virological.org/t/phylodynamic-analysis-129-genomes-24-feb-2020/356/.","References":[]},{"title2":"China National Health Commission, Policy and regulatory documents; www.nhc.gov.cn/wjw/gfxwjj/list.shtml.","References":[]},{"title2":"SenPei-CU/COVID-19, Data and code posting; https://github.com/SenPei-CU/COVID-19.","References":[]},{"title2":"Field Briefing, Diamond Princess COVID-19 Cases, 20 Feb Update; www.niid.go.jp/niid/en/2019-ncov-e.html.","References":[]},{"title2":"Tencent Big Data Platform; https://heat.qq.com.","References":[]},{"title2":"Inferring spatial interaction patterns from sequential snapshots of spatial distributions","References":[]},{"title2":"Plug-and-play inference for disease dynamics: Measles in large and small populations as a case study","References":[{"title3":"On the spread of a disease with gamma distributed latent and infectious periods"},{"title3":"Scalable implementations of ensemble filter algorithms for data assimilation"},{"title3":"A tutorial on particle filters for online nonlinear, non-Gaussian Bayesian tracking"},{"title3":"Some problems in the statistical analysis of epidemic data"},{"title3":"On estimating the latent and infectious periods of measles: I. Families with two susceptibles only"},{"title3":"Measles periodicity and community size"},{"title3":"Interepidemic intervals in forced and unforced SEIR models"},{"title3":"Exact and computationally efficient likelihood-based estimation for discretely observed diffusion processes (with discussion)"},{"title3":"Noisy clockwork: time series analysis of population fluctuations in animals"},{"title3":"Hazards, spatial transmission and timing of outbreaks in epidemic metapopulations"},{"title3":"Dynamics of measles epidemics: estimating scaling of transmission rates using a time series SIR model"},{"title3":"Space, persistence and dynamics of measles epidemics"},{"title3":"Impact of vaccination on the spatial correlation and persistence of measles dynamics"},{"title3":"Time series analysis via mechanistic models"},{"title3":"K-leap method for accelerating stochastic simulation of coupled chemical reactions"},{"title3":"An overview of existing methods and recent advances in sequential Monte Carlo"},{"title3":"Likelihood-based estimation of continuous-time epidemic models from time-series data: application to measles transmission in London"},{"title3":"Estimating the impact of school closure on influenza transmission from sentinel data"},{"title3":"Population time series: process variability, observation errors, missing values, lags, and hidden states"},{"title3":"Seasonality and the persistence and invasion of measles"},{"title3":"Resolving the impact of waiting time distributions on the persistence of measles"},{"title3":"Estimation of multiple transmission rates for epidemics in heterogeneous populations"},{"title3":"Skeletons, noise and population growth: the end of an old debate?"},{"title3":"Nonlinear population dynamics: models, experiments, and data"},{"title3":"A simple model for complex dynamical transitions in epidemics"},{"title3":"Noise and nonlinearity in measles epidemics: combining mechanistic and statistical approaches to population modeling"},{"title3":"The dynamics of measles in sub-Saharan Africa"},{"title3":"Measles in England and Wales:I: an analysis of factors underlying seasonal patterns"},{"title3":"Time series modelling of childhood diseases: a dynamical systems approach"},{"title3":"A stochastic model for extinction and recurrence of epidemics: estimation and inference for measles outbreaks"},{"title3":"Estimating parameters in stochastic compartmental models using Markov chain methods"},{"title3":"Likelihood estimation for stochastic compartmental models using Markov chain methods"},{"title3":"Interpreting time-series analyses for continuous-time biological models: measles as a case study"},{"title3":"Cities and villages: infection hierarchies in a measles metapopulation"},{"title3":"Seasonality and extinction in chaotic metapopulations"},{"title3":"Travelling waves and spatial hierarchies in measles epidemics"},{"title3":"Dynamics of measles epidemics: Scaling noise, determinism, and predictability with the TSIR model"},{"title3":"Modeling of childhood infectious diseases."},{"title3":"The period of transmission in certain epidemic diseases: an observational method for its discovery"},{"title3":"Infectiousness of communicable diseases in the household: measles, chickenpox, and mumps"},{"title3":"Maximum smoothed likelihood estimation"},{"title3":"Inference for nonlinear dynamical systems"},{"title3":"Modeling disease dynamics: cholera as a case study"},{"title3":"Iterated filtering. ()"},{"title3":"Disease extinction and community size: modeling the persistence of measles"},{"title3":"Understanding the persistence of measles: reconciling theory, simulation and observation"},{"title3":"Estimating spatial coupling in epidemiological systems: a mechanistic approach"},{"title3":"On methods for studying stochastic disease dynamics"},{"title3":"Equation-free: the computer-assisted analysis of complex, multiscale systems"},{"title3":"Inapparent infections and cholera dynamics"},{"title3":"Universal parameter optimisation in games based on SPSA"},{"title3":"Disentangling extrinsic from intrinsic factors in disease dynamics: a nonlinear time series approach with an application to cholera"},{"title3":"Mathematical and computational challenges in population biology and ecosystems science"},{"title3":"A link between the North Atlantic Oscillation and measles dynamics during the vaccination period in England and Wales"},{"title3":"Combining parameter and state estimation in simulation-based filtering"},{"title3":"Influence of nonlinear incidence rates upon the behavior of SIRS epidemiological models"},{"title3":"Destabilization of epidemic models with the inclusion of realistic distributions of infectious periods"},{"title3":"Realistic distributions of infectious periods in epidemic models: changing patterns of persistence and dynamics"},{"title3":"Superspreading and the effect of individual variation on disease emergence"},{"title3":"Uses and abuses of mathematics in biology"},{"title3":"Monte Carlo inference for state-space models of wild animal populations"},{"title3":"Practical filtering with sequential parameter learning"},{"title3":"Gradient-free maximum likelihood parameter estimation with particle filters"},{"title3":"On inference for partially observed nonlinear diffusion models using the Metropolis-Hastings algorithm"},{"title3":"An age-structured model of pre- and post-vaccination measles transmission"},{"title3":"Seasonal dynamics of recurrent epidemics"},{"title3":"Particle filters for state-space models with the presence of unknown static parameters"},{"title3":"Bayesian analysis of experimental epidemics of foot-and-mouth disease"},{"title3":"Approximate Bayesian computation scheme for parameter inference and model selection in dynamical systems"},{"title3":"Estimation of measles reproduction ratios and prospects for elimination of measles by vaccination in some western European countries"},{"title3":"Appropriate models for the management of infectious diseases"},{"title3":"Measles metapopulation dynamics: a gravity model for epidemiological coupling and dynamics"}]},{"title2":"A tutorial on particle filters for online nonlinear/non-Gaussian Bayesian tracking","References":[]},{"title2":"An ensemble adjustment Kalman filter for data assimilation","References":[]},{"title2":"Obstacles to high-dimensional particle filtering","References":[]},{"title2":"Comparison of filtering methods for the modeling and retrospective forecasting of influenza epidemics","References":[{"title3":"The annual impact of seasonal influenza in the US: Measuring disease burden and costs"},{"title3":"Real-time epidemic monitoring and forecasting of H1N1-2009 using influenza-like illness from general practice and family doctor clinics in Singapore"},{"title3":"Tracking epidemics with google flu trends data and a state-space SEIR model"},{"title3":"Forecasting seasonal outbreaks of influenza"},{"title3":"Monitoring and prediction of an epidemic outbreak using syndromic observations"},{"title3":"Shaman J, Karspeck A, Lipsitch M (2013) Week 1 Influenza Forecast for the 2012-2013 US Season. arXiv: 1301.3110."},{"title3":"Real-time influenza forecasts during the 2012-2013 season"},{"title3":"Centers for Disease Control and Prevention (2013) FluView. http://www.cdc.gov/flu/weekly/ "},{"title3":"Predicting the Epidemic Sizes of Influenza A/H1N1, A/H3N2, and B: A Statistical Method"},{"title3":"Google.org (2013) Google Flu Trend. http://www.google.org/flutrends "},{"title3":"Absolute Humidity and the Seasonal Onset of Influenza in the Continental United States"},{"title3":"Absolute humidity modulates influenza survival, transmission, and seasonality"},{"title3":"A non-Gaussian ensemble filter update for data assimilation"},{"title3":"Evensen G (2008) Sequential data assimilation. Data Assimilation: The ensemble Kalman filter. 2nd ed. New York: Springer. pp. 27-46."},{"title3":"Dukic VM, Lopes HF, Polson N (2009) Tracking Flu Epidemics Using Google Flu Trends and Particle Learning. SSRN: http://ssrn.com/abstract=1513705 or http://dx.doi.org/10.2139/ssrn.1513705 "},{"title3":"Inference for nonlinear dynamical systems"},{"title3":"Inference for nonlinear epidemiological models using genealogies and time series"},{"title3":"A tutorial on particle filters for online nonlinear/non-Gaussian Bayesian tracking"},{"title3":"Particle Filtering in Geophysical Systems"},{"title3":"Particle Markov chain Monte Carlo methods"},{"title3":"An Ensemble Adjustment Kalman Filter for Data Assimilation"},{"title3":"Iterated filtering"},{"title3":"Inapparent infections and cholera dynamics"},{"title3":"Plug-and-play inference for disease dynamics: measles in large and small populations as a case study"},{"title3":"Mechanistic modelling of the three waves of the 1918 influenza pandemic"},{"title3":"A new approach to linear filtering and prediction problems"},{"title3":"Experimental Implementation of an Ensemble Adjustment Filter for an Intermediate ENSO Model"},{"title3":"Obstacles to High-Dimensional Particle Filtering"},{"title3":"How generation intervals shape the relationship between growth rates and reproductive numbers"},{"title3":"Reassessing google flu trends data for detection of seasonal and pandemic influenza: a comparative epidemiological study at three geographic scales"},{"title3":"Assessing Google Flu Trends Performance in the United States during the 2009 Influenza Virus A (H1N1) Pandemic"},{"title3":"Comparison of Ensemble Kalman Filters under Non-Gaussianity"}]},{"title2":"Inference and forecast of the current West African ebola outbreak in Guinea, sierra leone and liberia","References":[{"title3":"Chan, M. Ebola virus disease in West Africa:no early end to the outbreak. New England Journal of Medicine .2014; 371:1183-1185. "},{"title3":"WHO Ebola Response Team (2014) Ebola Virus Disease in West Africa : The First 9 Months of the Epidemic and Forward Projections. New England Journal of Medicine: September 23, 2014, doi: 10.1056/NEJMoa1411100. "},{"title3":"King AA, Ionides EL, Pascual M, Bouma MJ. Inapparent infections and cholera dynamics. Nature. 2008;454(7206):877-880. "},{"title3":"Ong JB, Chen MI-C, Cook AR, Lee HC, Lee VC, Lin RTP, Tambyah PA, Goh LG. Real-time epidemic monitoring and forecasting of H1N1-2009 using influenza-like illness from general practice and family doctor clinics in Singapore. Plos One 2010; 5(4):e10036. "},{"title3":"Shaman J, Karspeck A, Yang W, Tamerius J, Lipsitch M. Real-time influenza forecasts during the 2012-2013 season. Nat Commun 2013; 4:2837. "},{"title3":"WHO Ebola Response Roadmap Situation Report, 1 October 2014, http://apps.who.int/iris/bitstream/10665/135600/1/roadmapsitrep_1Oct2014_eng.pdf?ua=1 "},{"title3":"Du Toit A. Ebola virus in West Africa. Nature Reviews Microbiology. 2014; 12:312. "},{"title3":"Tellier R. Aerosol transmission of influenza A virus: a review of new studies. Journal of the Royal Society Interface. 2009; rsif20090302. "},{"title3":"Shaman J, Karspeck A. Forecasting seasonal outbreaks of influenza. Proc Natl Acad Sci USA 2012;109(50):20425-20430. "},{"title3":"Yang W, Karspeck A, Shaman J. Comparison of filtering methods for the modeling and retrospective forecasting of influenza epidemics. PLoS Comput Biol. 2014;10(4):e1003583. "},{"title3":"Astacio J, Briere D, Guillen M, Martinez J, Rodriguez F, Valenzuela-Campos N. Biometrics Unit Technical Reports: Number BU-1365-M: Mathematical Models to Study the Outbreaks of Ebola. 1996. "},{"title3":"Legrand J, Grais R, Boelle P, Valleron A, Flahault A. Understanding the dynamics of Ebola epidemics. Epidemiol Infect. 2007;135: 610. "},{"title3":"Gomes MFC, Pastore y Piontti A, Rossi L, Chao D, Longini I, Halloran ME, Vespignani A. Assessing the International Spreading Risk Associated with the 2014 West African Ebola Outbreak. PLOS Currents Outbreaks. 2014 Sep 2. Edition 1. doi: 10.1371/currents.outbreaks.cd818f63d40e24aef769dda7df9e0da5. "},{"title3":"Anderson JL. An Ensemble Adjustment Kalman Filter for Data Assimilation. Mon. Weather Rev. 2001;129(12):2884-2903. "},{"title3":"Anderson JL. An adaptive covariance inflation error correction algorithm for ensemble filters. Tellus A, 2007;59: 210-224. "},{"title3":"Anderson JL. Spatially and temporally varying adaptive covariance inflation for ensemble filters. Tellus A. 1009; 61: 72-83. "},{"title3":"Towers S, Patterson-Lomba O, Castillo-Chavez C. Temporal Variations in the Effective Reproduction Number of the 2014 West Africa Ebola Outbreak. PLOS Currents Outbreaks. 2014 Sep 18. Edition 1. doi: 10.1371/currents.outbreaks.9e4c4294ec8ce1adad283172b16bc908. "},{"title3":"Plachouras D, Sudre B, Testa M, Robesyn E, Coulombier D. Letter to the editor: Early transmission dynamics of Ebola virus disease (EVD), West Africa, March to August 2014 - Eurosurveillance 17 September 2014. Euro Surveill. 2014;19(37):pii=20907. "},{"title3":"Meltzer MI, Atkins CY, Santibanez S, Knust B, Petersen BW, Ervin ED, Nichol ST, Damon IK, Washington ML. Estimating the future number of cases in the Ebola epidemic:Liberia and Sierra Leone, 2014-2015. Morb Mortal Wkly Rep. 2014;63: 1-14. "},{"title3":"Rivers CM, Lofgren ET, Marathe M, Eubank S, Lewis BL. Modeling the Impact of Interventions on an Epidemic of Ebola in Sierra Leone and Liberia. arXiv:1409.4607 [q-bio.PE], 2014. "},{"title3":"Columbia prediction of infectious diseases: Ebola forecasts. New York, NY: Columbia Mailman School of Public Health; 2014. "}]},{"title2":"Ensemble forecast of human West Nile virus cases and mosquito infection rates","References":[{"title3":"Origin of the West Nile virus responsible for an outbreak of encephalitis in the Northeastern United States"},{"title3":"West Nile Virus and other nationally notifiable arboviral diseases-United States, 2014"},{"title3":"Epidemiology of neuroinvasive arboviral disease in the United States, 1999-2007"},{"title3":"Estimated cumulative incidence of West Nile virus infection in US adults, 1999-2010"},{"title3":"West Nile fever characteristics among viremic persons identified through blood donor screening"},{"title3":"West Nile virus: review of the literature"},{"title3":"Vaccines and immunotherapeutics for the prevention and treatment of infections with West Nile virus"},{"title3":"The global emergence/resurgence of arboviral diseases as public health problems"},{"title3":"Differential impact of West Nile virus on California birds"},{"title3":"Host heterogeneity dominates West Nile virus transmission"},{"title3":"Vector competence of North American mosquitoes (diptera: culicidae) for West Nile virus"},{"title3":"Differential virulence of West Nile strains for American crows"},{"title3":"Migratory birds modeled as critical transport agents for West Nile virus in North America"},{"title3":"Lack of evidence of increased West Nile virus disease severity in the United States in 2012"},{"title3":"Surveillance for human West Nile virus disease:United States, 1999-2008"},{"title3":"West Nile virus and other nationally notifiable arboviral diseases-United States, 2014"},{"title3":"Forecasting seasonal outbreaks of influenza"},{"title3":"Real-time influenza forecasts during the 2012-2013 season"},{"title3":"Inference and Forecast of the Current West African Ebola Outbreak in Guinea, Sierra Leone and Liberia"},{"title3":"Forecasting influenza epidemics in Hong Kong"},{"title3":"Real-time epidemic monitoring and forecasting of H1N1-2009 using influenza-like illness from general practice and family doctor clinics in Singapore"},{"title3":"An ensemble adjustment Kalman filter for data assimilation"},{"title3":"Culex nigripalpus: seasonal shift in the bird-mammal feeding ratio in a mosquito vector of human encephalitis"},{"title3":"West Nile virus epidemics in North America are driven by shifts in mosquito feeding behavior"},{"title3":"Host feeding pattern of Culex quinquefasciatus (Diptera: Culicidae) and its role in transmission of West Nile virus in Harris County, Texas"},{"title3":"Vector host-feeding preferences drive transmission of multi-host pathogens: West Nile virus as a model system"},{"title3":"West Nile virus in overwintering Culex mosquitoes, New York City, 2000"},{"title3":"Effects of temperature on the transmission of West Nile virus by Culex tarsalis (Diptera: Culicidae)"},{"title3":"Confidence intervals for the difference of two proportions estimated from pooled samples"},{"title3":"Centers for Disease Control and Prevention. West Nile virus disease cases and deaths reported to CDC by year and clinical presentation, 1999-2014 (CDC, Atlanta, GA, USA, 2015) http://www.cdc.gov/westnile/statsMaps/cumMapsData.html."},{"title3":"Comparison of filtering methods for the modeling and retrospective forecasting of influenza epidemics"},{"title3":"An epidemiological model for West Nile virus: invasion analysis and control applications"},{"title3":"Effects of temperature on emergence and seasonality of West Nile virus in California"},{"title3":"Experimental infection of North American birds with the New York 1999 strain of West Nile virus"}]},{"title2":"Retrospective parameter estimation and forecast of respiratory syncytial virus in the United States","References":[{"title3":"The Burden of Respiratory Syncytial Virus Infection in Young Children"},{"title3":"Impact of Viral Respiratory Diseases on Infants and Young Children in a Rural and Urban Area of Southern West Virginia"},{"title3":"Risk of Primary Infection and Reinfection With Respiratory Syncytial Virus"},{"title3":"Respiratory Syncytial Virus-associated Hospitalizations Among Infants and Young Children in the United States, 1997-2006"},{"title3":"Use of Respiratory Syncytial Virus Surveillance Data to Optimize the Timing of Immunoprophylaxis"},{"title3":"The quality gap: Searching for the consequences of emergency department crowding"},{"title3":"Estimating the hospitalization burden associated with influenza and respiratory syncytial virus in New York City, 2003-2011"},{"title3":"Older Patients in the Emergency Department: A Review"},{"title3":"Emergency Department Crowding Is Associated With Decreased Quality of Care for Children With Acute Asthma"},{"title3":"When do infants need additional inspired oxygen? A review of the current literature"},{"title3":"Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis"},{"title3":"American Academy of Pediatrics 2014 Bronchiolitis Guidelines: Bonfire of the Evidence"},{"title3":"Bronchiolitis in children: diagnosis and management: NICE guidelines [NG9]. NICE; 2015."},{"title3":"The effect of chronic or intermittent hypoxia on cognition in childhood: a review of the evidence"},{"title3":"Oxygen therapy for bronchiolitis"},{"title3":"Oxygen Therapy for Bronchiolitis: In Reply"},{"title3":"Potential Role of Soluble TRAIL in Epithelial Injury in Children with Severe RSV Infection"},{"title3":"Acute lung injury in pediatric intensive care in Australia and New Zealand-A prospective, multicenter, observational study"},{"title3":"Data-driven quality improvement in the Emergency Department at a level one trauma and tertiary care hospital"},{"title3":"Data-driven process and operational improvement in the emergency department: the ED Dashboard and Reporting Application"},{"title3":"Modeling epidemics caused by respiratory syncytial virus (RSV)"},{"title3":"Environmental Drivers of the Spatiotemporal Dynamics of Respiratory Syncytial Virus in the United States"},{"title3":"Understanding the transmission dynamics of respiratory syncytial virus using multiple time series and nested models"},{"title3":"Respiratory syncytial virus infections in infants: Quantitation and duration of shedding"},{"title3":"Influence of age, severity of infection, and co-infection on the duration of respiratory syncytial virus (RSV) shedding"},{"title3":"Latency and persistence of respiratory syncytial virus despite T cell immunity"},{"title3":"Forecasting Influenza Epidemics in Hong Kong"},{"title3":"Comparison of filtering methods for the modeling and retrospective forecasting of influenza epidemics"},{"title3":"Inference and forecast of the current west african ebola outbreak in Guinea, sierra leone and liberia"},{"title3":"Prospective clinical and serological follow-up in early childhood reveals a high rate of subclinical RSV infection and a relatively high reinfection rate within the first 3 years of life"},{"title3":"Impact of viral respiratory diseases on infants and young children in a rural and urban area of southern West Virginia"},{"title3":"Real-time influenza forecasts during the 2012-2013 season"},{"title3":"Experimental implementation of an ensemble adjustment filter for an intermediate ENSO model"},{"title3":"An Ensemble Adjustment Kalman Filter for Data Assimilation"},{"title3":"Forecasting seasonal outbreaks of influenza"},{"title3":"Ensemble Data Assimilation without Perturbed Observations"},{"title3":"Flexible Modeling of Epidemics with an Empirical Bayes Framework"},{"title3":"Real-time epidemic monitoring and forecasting of H1N1-2009 using influenza-like illness from general practice and family doctor clinics in Singapore"},{"title3":"The gracefully aging immune system"},{"title3":"Effects of aging on the adaptive immune response to respiratory virus infections"},{"title3":"Experimental infection of humans with A2 respiratory syncytial virus"},{"title3":"Superinfection between Influenza and RSV Alternating Patterns in San Luis Potosi State, Mexico"},{"title3":"RSV vaccine: Beating the virus at its own game"}]},{"title2":"On the definition and the computation of the basic reproduction ratio R0 in models for infectious diseases in heterogeneous populations","References":[]},{"title2":"The construction of next-generation matrices for compartmental epidemic models","References":[]}]},{"title1":"Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single centers observational study","References":[{"title2":"Diagnosis and treatment of 2019 novel coronavirus infection in children: a pressing issue","References":[{"title3":"National Health Commission of People's Republic of China. https://www.nhc.gov.cn/xcs/yqfkdt/202001/a53e6df293cc4ff0b5a16ddf7b6b2b31.shtml. Accessed 30 Jan 2020."},{"title3":"Clinical analysis of pediatric SARS cases in Beijing"},{"title3":"Concern for severe acute respiratory syndrome"},{"title3":"Middle East respiratory syndrome coronavirus in children"},{"title3":"Inhibition of respiratory virus infection by locally applied interferon"},{"title3":"A multicenter randomized controlled clinical study of recombinant human interferon-typealpha1b in the treatment of viral pneumonia in children"},{"title3":"A multicenter study on the treatment of acute bronchiolitis by nebulized human recombinant human interferon-alpha 1b"},{"title3":"Effect of nebulized inhalation of recombinant human interferon alpha-1b on early treatment of severe hand, foot and mouth disease"},{"title3":"Rational use of interferon alpha in pediatrical clinical practice: experts' consensus statement"},{"title3":"A multicenter, randomized, controlled clinical study on the efficacy and safety of recombinant human interferon 2b spray (pseudomonas) in the treatment of acute upper respiratory tract infection in children"},{"title3":"Experimental study on the prevention and treatment of SARS-CoV infection in rhesus monkeys with recombinant human interferon 2b nasal spray"},{"title3":"Study on the pharmacodynamics of recombinant human interferon alpha 2b against respiratory viruses"},{"title3":"Experimental study of recombinant human interferon 2b aerosol in the prevention of respiratory virus infections such as SARS in human populations"},{"title3":"National Health Commission of People's Republic of China. Diagnosis and treatment of pneumonia caused by novel coronavirus (trial version 4). 2020. https://www.nhc.gov.cn/xcs/zhengcwj/202001/4294563ed35b43209b31739bd0785e67/files/7a9309111267475a99d4306962c8bf78.pdf. Accessed 28 Jan 2020."}]},{"title2":"National Health Commission of People's Republic of China. http://en.nhc.gov.cn/2020-02/24/c_76911.htm. Accessed 24 Feb 2020","References":[]},{"title2":"Pathogenicity and transmissibility of 2019-nCoV:a quick overview and comparison with other emerging viruses","References":[{"title3":"A novel coronavirus outbreak of global health concern"},{"title3":"Another decade, another coronavirus"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from patients with acute respiratory disease in Wuhan, Hubei, China"},{"title3":"Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak"},{"title3":"Assessing the pandemic potential of MERS-CoV"},{"title3":"Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions"},{"title3":"Complexity of the basic reproduction number (R0)"},{"title3":"Modelling the epidemic trend of the 2019 novel coronavirus outbreak in China"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"A novel coronavirus emerging in China : key questions for impact assessment"},{"title3":"Reproduction numbers of infectious disease models"},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies"},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"}]},{"title2":"Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)","References":[{"title3":"Distinguishing opinion from evidence in guidelines"},{"title3":"GRADE handbook, GRADE working group. 2013. https://gdt.gradepro.org/app/handbook/handbook.html. Accessed 22 Jan 2020."},{"title3":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations"},{"title3":"McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome"},{"title3":"Jin YH, Cai L, Cheng ZS, Cheng H, Deng T, Fan YP, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (Full version). Yixue Xinzhi. 2020;30(1):35-64. 10.12173/j.issn.1004-5511.2020.01.09 [Article in China]."},{"title3":"Chan JFW, Yuan S, Kok KH, To KKT, Chu HC, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020. 10.1016/S0140-6736(20)30154-9."},{"title3":"Health Emergency Office of National Health Commission of the PRC. Update on the epidemic of novel coronavirus (2019-nCoV) infected pneumonia as at 24:00 on 26 January. http://www.nhc.gov.cn/xcs/yqfkdt/202001/3882fdcdbfdc4b4fa4e3a829b62d518e.shtml. Accessed 26 Jan 2020."},{"title3":"Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020. https://doi.org/10.1038/s41586-020-2012-7."},{"title3":"Perlman S. Another decade, another coronavirus. N Engl J Med. 2020. 10.1056/NEJMe2001126."},{"title3":"Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020. 10.1056/NEJMoa2001017."},{"title3":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020. 10.1016/S0140-6736(20)30183-5."},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Middle East respiratory syndrome infection control and prevention guideline for healthcare facilities"},{"title3":"Image of pulmonary and diagnosis of atypicalnovel coronavirus (2019-nCoV) infected pneumonia: case series of 14 patients"},{"title3":"Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Treatment of severe acute respiratory syndrome"},{"title3":"MERS-COV disease associated ARDS -a case report"},{"title3":"The possibility of using Lopinave/Litonawe (LPV/r) as treatment for novel coronavirus 2019-nCov pneumonia: a quick systematic review based on earlier coronavirus clinical studies"},{"title3":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques"},{"title3":"Treatment with lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset"},{"title3":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study"},{"title3":"Middle east respiratory syndrome (MERS): a systematic review"},{"title3":"Clinical analysis of 190 cases of outbreak with atypical pneumonia in Guangzhou in spring, 2003"},{"title3":"Use of glucocorticoid in treatment of severe acute respiratory syndrome cases"},{"title3":"Glucocorticoid-induced diabetes in severe acute respiratory syndrome: the impact of high dosage and duration of methylprednisolone therapy"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"}]},{"title2":"Novel coronavirus infection in hospitalized infants under 1 year of age in China","References":[]},{"title2":"National Health Commission. Diagnosis and treatment of pneumonia caused by 2019-nCoV (trial version 6). https://baijiahao.baidu.com/s?id=1658945855347500695&amp;wfr=spider&amp;for=pc. Accessed 18 Feb 2020","References":[]},{"title2":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","References":[{"title3":"The 2019-nCoV Outbreak Joint Field Epidemiology Investigation Team, Li Q. Notes from the field: an outbreak of NCIP (2019-nCoV) infection in China : Wuhan, Hubei Province, 2019-2020."},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases : Wuhan, China 2019-2020."},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Use of national pneumonia surveillance to describe influenza A(H7N9) virus epidemiology, China, 2004-2013."},{"title3":"A novel coronavirus emerging in China : key questions for impact assessment."},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus."},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome."},{"title3":"Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future."},{"title3":"Coronavirus infections : more than just the common cold."},{"title3":"Another decade, another coronavirus."},{"title3":"SARS and MERS: recent insights into emerging coronaviruses."},{"title3":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at January 2020."},{"title3":"How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count."}]},{"title2":"Transmission dynamics of 2019 novel coronavirus (2019-nCoV)","References":[]},{"title2":"Characteristics of and public health responses to the coronavirus disease 2019 outbreak in China","References":[{"title3":"Report on the Current Situation of Pneumonia in Wuhan (2019-12-31)"},{"title3":"National Health Commission and Relevant Departments Jointly Prevent and Control New Coronavirus Infected Pneumonia"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China"},{"title3":"Gorbalenya. Severe acute respiratory syndrome-related coronavirus:The species and its viruses, a statement of the Coronavirus Study Group"},{"title3":"Coronavirus disease 2019 (COVID-19) Situation Reports"},{"title3":"Report on the Current Situation of Pneumonia in Wuhan (2020-01-05)"},{"title3":"Report on the Current Situation of Pneumonia in Wuhan (2020-01-11)"},{"title3":"The Latest Situation of Pneumonia Caused by Novel Corona Virus"},{"title3":"World Health Organization Report"},{"title3":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV)"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Global epidemiology of bat coronaviruses"},{"title3":"Identification of residues critical for the human coronavirus 229E receptor function of human aminopeptidase N"},{"title3":"The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2"},{"title3":"Human coronaviruses OC43 and HKU1 bind to 9-O-acetylated sialic acids via a conserved receptor-binding site in spike protein domain A"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum"},{"title3":"Diagnosis &amp; Treatment Scheme for Novel Coronavirus Pneumonia (Trial) 6th Edition"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Global Network Report"},{"title3":"Technical Guide for Prevention and Control of New Coronavirus Infection in Medical Institutions (Second Edition) (2020-01-22)"},{"title3":"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February 2003"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"}]},{"title2":"Understanding of COVID-19 based on current evidence","References":[{"title3":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses-a statement of the coronavirus study group"},{"title3":"National Health Commission's briefing on the pneumonia epidemic situation (in Chinese)"},{"title3":"Emerging coronaviruses: genome structure, replication, and pathogenesis"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human"},{"title3":"The 2019-new coronavirus epidemic: evidence for virus evolution"},{"title3":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health-the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020"},{"title3":"Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov"},{"title3":"Cryo-EM structure of the SARS-CoV-2 spike in the prefusion conformation"},{"title3":"Clinical characteristics of 2019 novel coronavirus infection in China"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Drug treatment options for the 2019-new coronavirus (2019-nCoV)"},{"title3":"Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China"},{"title3":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Viral infection increases the risk of idiopathic pulmonary fibrosis: a meta-analysis"}]},{"title2":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72,314 cases from the Chinese Center for Disease Control and Prevention","References":[]},{"title2":"Coronavirus: covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate","References":[]},{"title2":"SARS and MERS: recent insights into emerging coronaviruses","References":[{"title3":"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Molecular epidemiology of the novel coronavirus that causes severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"WHO. Summary of probably SARS cases with onset of illness from 1 November 2002 to 31 July 2003. WHO, http://www.who.int/csr/sars/country/table2004_04_21/en/ (2004)."},{"title3":"SARS-CoV infection in a restaurant from palm civet"},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation"},{"title3":"Patient with new strain of coronavirus is treated in intensive care at London hospital"},{"title3":"Korea Centers for Disease Control and Prevention. Middle East respiratory syndrome coronavirus outbreak in the Republic of Korea, 2015. Osong Public Health Res. Perspect.6, 269-278 (2015)."},{"title3":"WHO. Coronavirus infections: disease outbreak news. WHO, http://www.who.int/csr/don/26-april-2016-mers-saudi-arabia/en/ (2016)."},{"title3":"Nidovirus transcription: how to make sense...?"},{"title3":"Coronaviruses post-SARS: update on replication and pathogenesis"},{"title3":"Coronaviruses: an overview of their replication and pathogenesis"},{"title3":"SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum"},{"title3":"Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage"},{"title3":"Infidelity of SARS-CoV nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing"},{"title3":"Insights into RNA synthesis, capping, and proofreading mechanisms of SARS-coronavirus"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Review of bats and SARS"},{"title3":"Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS"},{"title3":"Middle East respiratory syndrome coronavirus neutralizing serum antibodies in dromedary camels: a comparative serological study"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"MERS coronavirus in dromedary camel herd, Saudi Arabia"},{"title3":"Isolation of MERS coronavirus from a dromedary camel, Qatar, 2014"},{"title3":"MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983-1997"},{"title3":"Co-circulation of three camel coronavirus species and recombination of MERS-CoVs in Saudi Arabia"},{"title3":"Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study"},{"title3":"Transmission of Middle East respiratory syndrome coronavirus infections in healthcare settings, Abu Dhabi"},{"title3":"Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic"},{"title3":"Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Environmental contamination and viral shedding in MERS patients during MERS-CoV outbreak in South Korea"},{"title3":"The role of superspreading in Middle East respiratory syndrome coronavirus (MERS-CoV) transmission"},{"title3":"Middle East respiratory syndrome coronavirus superspreading event involving 81 persons, Korea 2015"},{"title3":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease"},{"title3":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"Temporal relationship of viral load, ribavirin, interleukin (IL)-6, IL-8, and clinical progression in patients with severe acute respiratory syndrome"},{"title3":"Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection"},{"title3":"Kinetics and pattern of viral excretion in biological specimens of two MERS-CoV cases"},{"title3":"Biomarkers in acute respiratory distress syndrome"},{"title3":"The mercurial nature of neutrophils: still an enigma in ARDS?"},{"title3":"SARS-CoV virus-host interactions and comparative etiologies of acute respiratory distress syndrome as determined by transcriptional and cytokine profiling of formalin-fixed paraffin-embedded tissues"},{"title3":"Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?"},{"title3":"Elucidating the molecular physiopathology of acute respiratory distress syndrome in severe acute respiratory syndrome patients"},{"title3":"Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome"},{"title3":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome"},{"title3":"Genome wide identification of SARS-CoV susceptibility loci using the Collaborative Cross"},{"title3":"Sensing of RNA viruses: a review of innate immune receptors involved in recognizing RNA virus invasion"},{"title3":"SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism"},{"title3":"MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV"},{"title3":"Rapid generation of a mouse model for Middle East respiratory syndrome"},{"title3":"MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-alpha treatment"},{"title3":"Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex"},{"title3":"In vitro reconstitution of SARS-coronavirus mRNA cap methylation"},{"title3":"Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-O-methyltransferase activity"},{"title3":"Coronavirus non-structural protein 16: evasion, attenuation, and possible treatments"},{"title3":"The nucleocapsid protein of coronaviruses acts as a viral suppressor of RNA silencing in mammalian cells"},{"title3":"SARS-CoV nucleocapsid protein antagonizes IFN-beta response by targeting initial step of IFN-beta induction pathway, and its C-terminal region is critical for the antagonism"},{"title3":"Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist"},{"title3":"Middle east respiratory syndrome coronavirus 4a protein is a double-stranded RNA-binding protein that suppresses PACT-induced activation of RIG-I and MDA5 in the innate antiviral response"},{"title3":"The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists"},{"title3":"Middle East respiratory syndrome coronavirus ORF4b protein inhibits type I interferon production through both cytoplasmic and nuclear targets"},{"title3":"Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism of IRF3 and NF-kappaB signaling"},{"title3":"Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus"},{"title3":"The SARS coronavirus papain like protease can inhibit IRF3 at a post activation step that requires deubiquitination activity"},{"title3":"Crystal structure of the Middle East respiratory syndrome coronavirus (MERS-CoV) papain-like protease bound to ubiquitin facilitates targeted disruption of deubiquitinating activity to demonstrate its role in innate immune suppression"},{"title3":"SARS coronavirus nsp1 protein induces template-dependent endonucleolytic cleavage of mRNAs: viral mRNAs are resistant to nsp1-induced RNA cleavage"},{"title3":"A two-pronged strategy to suppress host protein synthesis by SARS coronavirus nsp1 protein"},{"title3":"Severe acute respiratory syndrome coronavirus nsp1 facilitates efficient propagation in cells through a specific translational shutoff of host mRNA"},{"title3":"Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain"},{"title3":"Middle East respiratory syndrome coronavirus nsp1 inhibits host gene expression by selectively targeting mRNAs transcribed in the nucleus while sparing mRNAs of cytoplasmic origin"},{"title3":"Molecular determinants for subcellular localization of the severe acute respiratory syndrome coronavirus open reading frame 3b protein"},{"title3":"Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists"},{"title3":"MAVS-mediated apoptosis and its inhibition by viral proteins"},{"title3":"Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses"},{"title3":"Mechanisms of action of ribavirin against distinct viruses"},{"title3":"Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study"},{"title3":"Clinical analysis of the first patient with imported Middle East respiratory syndrome in China"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Development of a standard treatment protocol for severe acute respiratory syndrome"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study"},{"title3":"Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China"},{"title3":"Severe acute respiratory syndrome (SARS) in Singapore: clinical features of index patient and initial contacts"},{"title3":"Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics"},{"title3":"Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus"},{"title3":"Inhibition of novel beta coronavirus replication by a combination of interferon-alpha2b and ribavirin"},{"title3":"Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays"},{"title3":"Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines"},{"title3":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques"},{"title3":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study"},{"title3":"IFN-alpha2a or IFN-beta1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study"},{"title3":"Ribavirin and interferon-alpha2b as primary and preventive treatment for Middle East respiratory syndrome coronavirus: a preliminary report of two cases"},{"title3":"Treatment with lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a non-human primate model of common marmoset"},{"title3":"Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen"},{"title3":"Middle East respiratory syndrome-coronavirus infection: a case report of serial computed tomographic findings in a young male patient"},{"title3":"Kim, U. J., Won, E. J., Kee, S. J., Jung, S. I. &amp; Jang, H. C. Combination therapy with lopinavir/ritonavir, ribavirin and interferon-alpha for Middle East respiratory syndrome: a case report. Antivir. Ther.10.3851/IMP3002 (2015)."},{"title3":"Rhee, J. Y., Hong, G. &amp; Ryu, K. M. Clinical implications of five cases of Middle East respiratory syndrome coronavirus infection in South Korea Outbreak. Jpn J. Infect. Dis.10.7883/yoken.JJID.2015.445 (2016)."},{"title3":"From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design"},{"title3":"Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus"},{"title3":"Ligand-induced dimerization of Middle East respiratory syndrome (MERS) coronavirus nsp5 protease (3CLpro): implications for nsp5 regulation and the development of antivirals"},{"title3":"Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture"},{"title3":"International Severe Acute Respiratory &amp; Emerging Infection Consortium. Treatment of MERS-CoV: decision support tool. International Severe Acute Respiratory &amp; Emerging Infection Consortium, https://isaric.tghn.org/site_media/media/articles/Decision_Support_Document_v1_1_20130729.pdf (updated 29 July 2013)."},{"title3":"The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis"},{"title3":"A conformation-dependent neutralizing monoclonal antibody specifically targeting receptor-binding domain in Middle East respiratory syndrome coronavirus spike protein"},{"title3":"Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein"},{"title3":"Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution"},{"title3":"Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies"},{"title3":"Passive immunotherapy with dromedary immune serum in an experimental animal model for Middle East respiratory syndrome coronavirus infection"},{"title3":"Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo"},{"title3":"A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein"},{"title3":"Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus"},{"title3":"Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection"},{"title3":"Prophylaxis with a MERS-CoV-specific human monoclonal antibody protects rabbits from MERS-CoV infection"},{"title3":"3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012"},{"title3":"Inhibition of Middle East respiratory syndrome coronavirus infection by anti-CD26 monoclonal antibody"},{"title3":"Identification of a broad-spectrum antiviral small molecule against severe acute respiratory syndrome coronavirus and Ebola, Hendra, and Nipah viruses by using a novel high-throughput screening assay"},{"title3":"Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response"},{"title3":"Protease inhibitors targeting coronavirus and filovirus entry"},{"title3":"The role of C5a in acute lung injury induced by highly pathogenic viral infections"},{"title3":"Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus"},{"title3":"A decade after SARS: strategies for controlling emerging coronaviruses"},{"title3":"SARS vaccines: where are we?"},{"title3":"Middle East respiratory syndrome: current status and future prospects for vaccine development"},{"title3":"Evaluation of candidate vaccine approaches for MERS-CoV"},{"title3":"Recombinant receptor binding domain protein induces partial protective immunity in rhesus macaques against Middle East respiratory syndrome coronavirus challenge"},{"title3":"A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates"},{"title3":"Immune efficacy of first and repeat trivalent influenza vaccine in healthy subjects and hemodialysis patients"},{"title3":"Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study"},{"title3":"An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients"},{"title3":"Middle East respiratory syndrome"},{"title3":"Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome"},{"title3":"Association of higher MERS-CoV virus load with severe disease and death, Saudi Arabia, 2014"},{"title3":"Mortality risk factors for Middle East respiratory syndrome outbreak, South Korea, 2015"},{"title3":"Animal models for SARS and MERS coronaviruses"},{"title3":"Replication and shedding of MERS-CoV in Jamaican fruit bats (Artibeus jamaicensis)"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Civets are equally susceptible to experimental infection by two different severe acute respiratory syndrome coronavirus isolates"},{"title3":"Replication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels"},{"title3":"Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice"},{"title3":"SARS-like WIV1-CoV poised for human emergence"}]},{"title2":"2019-novel coronavirus infection in a three-month-old baby","References":[]},{"title2":"Recommendation for the diagnosis and treatment of novel coronavirus infection in children in Hubei (trial version 1)","References":[]},{"title2":"Effects of ageing on the immune system: infants to elderly","References":[]},{"title2":"New coronavirus: new challenges for pediatricians","References":[{"title3":"National Recommendations for Diagnosis and Treatment of pneumonia caused by 2019-nCoV (the 4th edition). National Health Commission and National Administrative Office of Chinese Traditional Medicine. https://www.nhc.gov.cn/xcs/zhengcwj/202001/4294563ed35b43209b31739bd0785e67/files/7a9309111267475a99d4306962c8bf78.pdf. Access 29 Jan 2020."},{"title3":"Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus"}]},{"title2":"Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in republic of Korea","References":[]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) in Mexico"},{"title3":"Critically ill patients with severe acute respiratory syndrome"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"KDIGO clinical practice guideline for acute kidney injury"},{"title3":"Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Short-term outcome of critically ill patients with severe acute respiratory syndrome"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"China built a hospital in 10 days to battle coronavirus"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Asymptomatic cases complicate efforts"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]},{"title2":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series","References":[]},{"title2":"Clinical and epidemiological characteristics of 34 children with 2019 novel coronavirus infection in Shenzhen","References":[]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Reducing mortality from 2019-nCoV: host-directed therapies should be an option","References":[{"title3":"Novel coronavirus (2019-nCoV) situation report - 14"},{"title3":"Severe acute respiratory syndrome: historical, epidemiologic, and clinical features"},{"title3":"The Middle East respiratory syndrome (MERS)"},{"title3":"Clinical features of patients infected with 2019 coronavirus in Wuhan, China"},{"title3":"Coronavirus infections and immune responses"},{"title3":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology"},{"title3":"Quality of life reported by survivors after hospitalization for Middle East respiratory syndrome (MERS)"},{"title3":"The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status"},{"title3":"Coronaviruses - drug discovery and therapeutic options"},{"title3":"Advances in respiratory virus therapeutics:a meeting report from the 6th ISIRV antiviral group conference"},{"title3":"Host-directed therapies for improving poor treatment outcomes associated with the Middle East respiratory syndrome coronavirus infections"},{"title3":"Effect of oral gavage treatment with ZnAL42 and other metallo-ion formulations on influenza A H5N1 and H1N1 virus infections in mice"},{"title3":"Cell therapy in acute respiratory distress syndrome"},{"title3":"Immune therapy in sepsis: are we ready to try again?"},{"title3":"Clinically relevant immune responses against cytomegalovirus: implications for precision medicine"}]},{"title2":"Severe acute respiratory syndrome: historical, epidemiologic, and clinical features","References":[{"title3":"Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China"},{"title3":"List of blue print priority diseases"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Summary of probable SARS cases with onset of illness from 1 November to 31 July 2003"},{"title3":"Coronaviruses - drug discovery and therapeutic options"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"The genome sequence of the SARS-associated coronavirus"},{"title3":"Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection"},{"title3":"Analysis on the characteristics of blood serum Ab-IgG detective result of severe acute respiratory syndrome patients in Guangzhou, China"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Prevalence of IgG antibody to SARS-associated coronavirus in animal traders--Guangdong province, China, 2003"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"SARS-CoV infection in a restaurant from palm civet"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Pathology and pathogenesis of severe acute respiratory syndrome"},{"title3":"Persistent infection of SARS coronavirus in colonic cells in vitro"},{"title3":"Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"The 3a protein of severe acute respiratory syndrome-associated coronavirus induces apoptosis in Vero E6 cells"},{"title3":"Overexpression of 7a, a protein specifically encoded by the severe acute respiratory syndrome coronavirus, induces apoptosis via a caspase-dependent pathway"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore"},{"title3":"Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS)"},{"title3":"Pegulated interferon-a protects type I pneumocytes against SARS coronavirus infection in macaques"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome"},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome"},{"title3":"T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice"},{"title3":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice"},{"title3":"Toll-like receptor 3 signaling via TRIF contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection"},{"title3":"The membrane protein of severe acute respiratory syndrome coronavirus functions as a novel cytosolic pathogen-associated molecular pattern to promote beta interferon induction via a Toll-like-receptor-related TRAF3-independent mechanism"},{"title3":"IL-12 RB1 genetic variants contribute to human susceptibility to severe acute respiratory syndrome infection among Chinese"},{"title3":"Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection"},{"title3":"Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection"},{"title3":"Epidemiology and cause of severe acute respiratory syndrome in Guangdong, People's Republic of China, in February 2003"},{"title3":"Severe acute respiratory syndrome"},{"title3":"The severe acute respiratory syndrome"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Index patient and SARS outbreak in Hong Kong"},{"title3":"The severe acute respiratory syndrome coronavirus in tears"},{"title3":"Temporal-spatial analysis of severe acute respiratory syndrome among hospital inpatients"},{"title3":"Role of fomites in SARS transmission during the largest hospital outbreak in Hong Kong"},{"title3":"Detection of airborne severe acute respiratory syndrome (SARS) coronavirus and environmental contamination in SARS outbreak units"},{"title3":"Update 95-SARS: chronology of a serial killer"},{"title3":"Why did outbreaks of severe acute respiratory syndrome occur in some hospital wards but not in others?"},{"title3":"Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review"},{"title3":"Viral load distribution in SARS outbreak"},{"title3":"Evidence of airborne transmission of the severe acute respiratory syndrome virus"},{"title3":"Severe acute respiratory syndrome beyond Amoy Gardens: completing the incomplete legacy"},{"title3":"Superspreading and the effect of individual variation on disease emergence"},{"title3":"Severe acute respiratory syndrome in children: experience in a regional hospital in Hong Kong"},{"title3":"Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Severe acute respiratory syndrome: clinical outcome and prognostic correlates"},{"title3":"Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome"},{"title3":"Possible central nervous system infection by SARS coronavirus"},{"title3":"Severe acute respiratory syndrome (SARS) in a geriatric patient with a hip fracture. A case report"},{"title3":"Clinical presentations and outcome of severe acute respiratory syndrome in children"},{"title3":"Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome"},{"title3":"Seroprevalence of IgG antibodies to SARS-coronavirus in asymptomatic or subclinical population groups"},{"title3":"SARS: clinical features and diagnosis"},{"title3":"Severe acute respiratory syndrome: correlation between clinical outcome and radiologic features"},{"title3":"Estimating variability in the transmission of severe acute respiratory syndrome to household contacts in Hong Kong, China"},{"title3":"Early diagnosis of SARS coronavirus infection by real time RT-PCR"},{"title3":"Quantitative analysis and prognostic implication of SARS coronavirus in the plasma and serum of patients with severe acute respiratory syndrome"},{"title3":"Serial analysis of the plasma concentration of SARS coronavirus RNA in pediatric patients with severe acute respiratory syndrome"},{"title3":"Anti-SARS-CoV IgG response in relation to disease severity of severe acute respiratory syndrome"},{"title3":"Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study"},{"title3":"Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis"},{"title3":"Temporal patterns of hepatic dysfunction and disease severity in patients with SARS"},{"title3":"Thin section CT of severe acute respiratory syndrome: evaluation of 73 patients exposed to or with the disease"},{"title3":"Short-term outcome of critically ill patients with severe acute respiratory syndrome"},{"title3":"Infants born to mothers with severe acute respiratory syndrome"},{"title3":"Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicenter retrospective matched cohort study"},{"title3":"Interferon Alfacon-1 plus corticosteroids in severe acute respiratory syndrome. A preliminary study"},{"title3":"Hemophagocytic syndrome and infection"},{"title3":"Coronavirus-positive nasopharyngeal aspirate as predictor for severe acute respiratory syndrome mortality"},{"title3":"Fatal aspergillosis in a patient with SARS who was treated with corticosteroids"},{"title3":"Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids"},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"Use of convalescent plasma therapy in SARS patients in Hong Kong"},{"title3":"Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients"},{"title3":"The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis"},{"title3":"Effects of a SARS-associated coronavirus vaccine in monkeys"},{"title3":"DNA vaccine of SARS-CoV S gene induces antibody response in mice"},{"title3":"A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice"},{"title3":"Pandemic planning in China: applying lessons from severe acute respiratory syndrome"},{"title3":"Infection prevention and control measures for acute respiratory infections in healthcare settings: an update"}]},{"title2":"The Middle East respiratory syndrome (MERS)","References":[]},{"title2":"Coronavirus infections and immune responses","References":[]},{"title2":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology","References":[{"title3":"Masters PS, Perlman, S (2013) Coronaviridae. In: Knipe DM, Howley P (eds) Fields Virology. Lippincott Williams and Wilkins, Philadelphia, PA, pp 825-858"},{"title3":"Coronavirus host range expansion and Middle East respiratory syndrome coronavirus emergence: biochemical mechanisms and evolutionary perspectives"},{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses"},{"title3":"Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus"},{"title3":"Coronavirus-associated pneumonia in previously healthy children"},{"title3":"Clinical disease in children associated with newly described coronavirus subtypes"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"van Boheemen S et al (2012) Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio 3(6)"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Coronaviruses post-SARS: update on replication and pathogenesis"},{"title3":"WHO Cumulative number of reported probable cases of SARS. In: 2003"},{"title3":"http://www.who.int/csr/disease/coronavirus_infections/MERS_CoV_RA_20140613.pdf WUoM-CTfAtHaIRfA-RGLaoMAf"},{"title3":"WHO: Middle East respiratory syndrome coronavirus (MERS-CoV). http://www.who.int/emergencies/mers-cov/en/"},{"title3":"Replication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels"},{"title3":"Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia"},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Clinical and laboratory findings of SARS in Singapore"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"Middle East respiratory syndrome coronavirus: a case-control study of hospitalized patients"},{"title3":"Middle East respiratory syndrome"},{"title3":"Severe acute respiratory syndrome"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"SARS: clinical virology and pathogenesis"},{"title3":"The pathology and pathogenesis of experimental severe acute respiratory syndrome and influenza in animal models"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"van den Brand JM et al (2014) The pathology and pathogenesis of experimental severe acute respiratory syndrome and influenza in animal models. J Comp Pathol 151(1):83-112"},{"title3":"Expression of lymphocytes and lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"A cluster of patients with severe acute respiratory syndrome in a chest ward in southern Taiwan"},{"title3":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014"},{"title3":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice"},{"title3":"Disease-promoting effects of type I interferons in viral, bacterial, and coinfections"},{"title3":"Age-dependent dysregulation of innate immunity"},{"title3":"Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis"},{"title3":"Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells"},{"title3":"Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro"},{"title3":"Temporal changes in cytokine/chemokine profiles and pulmonary involvement in severe acute respiratory syndrome"},{"title3":"Persistence of lung inflammation and lung cytokines with high-resolution CT abnormalities during recovery from SARS"},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome"},{"title3":"Analysis of serum cytokines in patients with severe acute respiratory syndrome"},{"title3":"Human immunopathogenesis of severe acute respiratory syndrome (SARS)"},{"title3":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome"},{"title3":"An interferon-gamma-related cytokine storm in SARS patients"},{"title3":"A probable role for IFN-gamma in the development of a lung immunopathology in SARS"},{"title3":"Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment"},{"title3":"Chu H et al (2015) Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways. J Infect Dis 213(6):904-14"},{"title3":"Middle East respiratory syndrome coronavirus shows poor replication but significant induction of antiviral responses in human monocyte-derived macrophages and dendritic cells"},{"title3":"Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis"},{"title3":"High secretion of interferons by human plasmacytoid dendritic cells upon recognition of Middle East respiratory syndrome coronavirus"},{"title3":"Clinical progression and cytokine profiles of Middle East respiratory syndrome coronavirus infection"},{"title3":"Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity"},{"title3":"Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans"},{"title3":"A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo"},{"title3":"Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice"},{"title3":"A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice"},{"title3":"SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism"},{"title3":"Age-related increases in PGD(2) expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice"},{"title3":"A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease"},{"title3":"Early upregulation of acute respiratory distress syndrome-associated cytokines promotes lethal disease in an aged-mouse model of severe acute respiratory syndrome coronavirus infection"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"Toll-like receptor 3 signaling via TRIF contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection"},{"title3":"The PDZ-binding motif of severe acute respiratory syndrome coronavirus envelope protein is a determinant of viral pathogenesis"},{"title3":"Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis"},{"title3":"Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques"},{"title3":"Asymptomatic Middle East respiratory syndrome coronavirus infection in rabbits"},{"title3":"Prophylaxis with a Middle East respiratory syndrome coronavirus (MERS-CoV)-specific human monoclonal antibody protects rabbits from MERS-CoV infection"},{"title3":"Infection with MERS-CoV causes lethal pneumonia in the common marmoset"},{"title3":"Intratracheal exposure of common marmosets to MERS-CoV Jordan-n3/2012 or MERS-CoV EMC/2012 isolates does not result in lethal disease"},{"title3":"Receptor variation and susceptibility to Middle East respiratory syndrome coronavirus infection"},{"title3":"Rapid generation of a mouse model for Middle East respiratory syndrome"},{"title3":"Animal models for SARS and MERS coronaviruses"},{"title3":"Animal models of Middle East respiratory syndrome coronavirus infection"},{"title3":"Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection"},{"title3":"Cockrell A et al (2016) A mouse model for MERS coronavirus-induced acute respiratory distress syndrome. Nature Microbiology 2:16226"},{"title3":"Li K et al (2017) Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice. Proceedings of the National Academy of Sciences 114(15):E3119-E3128"},{"title3":"Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane"},{"title3":"Interaction of SARS and MERS coronaviruses with the antiviral interferon response"},{"title3":"Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells"},{"title3":"Coronavirus papain-like proteases negatively regulate antiviral innate immune response through disruption of STING-mediated signaling"},{"title3":"Interferon and cytokine responses to SARS-coronavirus infection"},{"title3":"SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon"},{"title3":"Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain"},{"title3":"Fehr AR et al (2016) The Conserved Coronavirus Macrodomain Promotes Virulence and Suppresses the Innate Immune Response during Severe Acute Respiratory Syndrome Coronavirus Infection. mBio 7(6):e01721-16"},{"title3":"Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism of IRF3 and NF-kappaB signaling"},{"title3":"Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists"},{"title3":"SARS-CoV nucleocapsid protein antagonizes IFN-beta response by targeting initial step of IFN-beta induction pathway, and its C-terminal region is critical for the antagonism"},{"title3":"Suppression of innate antiviral response by severe acute respiratory syndrome coronavirus M protein is mediated through the first transmembrane domain"},{"title3":"Middle East respiratory syndrome coronavirus M protein suppresses type I interferon expression through the inhibition of TBK1-dependent phosphorylation of IRF3"},{"title3":"The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists"},{"title3":"Initial viral load and the outcomes of SARS"},{"title3":"Proliferative growth of SARS coronavirus in Vero E6 cells"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand"},{"title3":"Macrophage-expressed IFN-beta contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia"},{"title3":"Cellular inhibitor of apoptosis protein cIAP2 protects against pulmonary tissue necrosis during influenza virus infection to promote host survival"},{"title3":"T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice"},{"title3":"Adaptive immune cells temper initial innate responses"},{"title3":"Not so fast: adaptive suppression of innate immunity"},{"title3":"Transcriptomic analysis reveals a mechanism for a prefibrotic phenotype in STAT1 knockout mice during severe acute respiratory syndrome coronavirus infection"},{"title3":"Induction of alternatively activated macrophages enhances pathogenesis during severe acute respiratory syndrome coronavirus infection"},{"title3":"Genome wide identification of SARS-CoV susceptibility loci using the collaborative cross"},{"title3":"Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome"},{"title3":"Reghunathan R et al (2005) Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome. BMC Immunology 6:2"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study"},{"title3":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques"},{"title3":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study"},{"title3":"The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study"},{"title3":"High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome"},{"title3":"Corticosteroid treatment of severe acute respiratory syndrome in Hong Kong"},{"title3":"Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques"},{"title3":"Zumla A et al (2016) Coronaviruses:drug discovery and therapeutic options. Nat Rev Drug Discov 15(5):327-47"},{"title3":"IFNlambda is a potent anti-influenza therapeutic without the inflammatory side effects of IFNalpha treatment"},{"title3":"IFN-lambda resolves inflammation via suppression of neutrophil infiltration and IL-1beta production"},{"title3":"Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury"},{"title3":"The TLR4 antagonist Eritoran protects mice from lethal influenza infection"},{"title3":"Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection"},{"title3":"Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus"},{"title3":"Silencing of CCR2 in myocarditis"},{"title3":"Therapeutic siRNA silencing in inflammatory monocytes in mice"},{"title3":"Immunomodulatory therapy for severe influenza"},{"title3":"The effect of inhibition of PP1 and TNFalpha signaling on pathogenesis of SARS coronavirus"}]}]}]}